Nutanix (NTNX) 10-Q 24 May 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jan. 31, 2023	Apr. 30, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2023
Document Transition Report	false
Entity File Number	001-37883
Entity Registrant Name	NUTANIX, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0989767
Entity Address, Address Line One	1740 Technology Drive, Suite 150
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95110
City Area Code	(408)
Local Phone Number	216-8360
Title of 12(b) Security	Class A Common Stock, $0.000025 par value per share
Trading Symbol	NTNX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		235,744,027
Entity Central Index Key	0001618732
Current Fiscal Year End Date	--07-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Current assets:
Cash and cash equivalents	$ 406,601	$ 402,850
Short-term investments	904,763	921,429
Accounts receivable, net of allowances of $644 and $472, respectively	155,258	124,559
Deferred commissions—current	109,363	115,356
Prepaid expenses and other current assets	115,763	93,787
Total current assets	1,691,748	1,657,981
Property and equipment, net	112,584	113,440
Operating lease right-of-use assets	106,711	118,740
Deferred commissions—non-current	239,117	252,234
Intangible assets, net	9,941	15,829
Goodwill	185,260	185,260
Other assets—non-current	26,134	22,265
Total assets	2,371,495	2,365,749
Liabilities and Stockholders’ Deficit
Deferred revenue—non-current	738,816	724,545
Operating lease liabilities—non-current	80,585	89,782
Convertible senior notes, net	1,186,764	1,156,205
Other liabilities—non-current	35,745	35,161
Total liabilities	3,154,177	3,166,253
Current liabilities:
Accounts payable	44,070	44,931
Accrued compensation and benefits	138,343	149,811
Accrued expenses and other current liabilities	108,258	59,568
Deferred revenue—current	787,495	720,993
Operating lease liabilities—current	34,101	39,801
Convertible senior notes, net-current	0	145,456
Total current liabilities	1,112,267	1,160,560
Commitments and contingencies (Note 8)
Stockholders’ deficit:
Preferred stock, par value of $0.000025 per share- 200,000 shares authorized as of July 31, 2022 and January 31, 2023; no shares issued and outstanding as of July 31, 2022 and January 31, 2023	0	0
Common stock, par value of $0.000025 per share-1,042,004 (1,000,000 Class A, 42,004 Class B) and 1,000,000 Class A shares authorized as of July 31, 2022 and January 31, 2023, respectively; 226,938 and 233,591 Class A shares issued and outstanding as of July 31, 2022 and January 31, 2023, respectively	6	6
Additional paid-in capital	3,771,779	3,583,928
Accumulated other comprehensive (loss) income	(5,801)	(6,076)
Accumulated deficit	(4,548,666)	(4,378,362)
Total stockholders’ deficit	(782,682)	(800,504)
Total liabilities and stockholders’ deficit	$ 2,371,495	$ 2,365,749

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Accounts receivable, allowance for credit loss	$ 472	$ 644
Preferred stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	1,042,004,000	1,042,004,000
Common Class A [Member]
Common stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	233,591,000	226,938,000
Common stock, shares outstanding (in shares)	233,591,000	226,938,000
Common Class B [Member]
Common stock, par value (in dollars per share)	$ 0.000025	$ 0.000025
Common stock, shares authorized (in shares)		42,004,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Revenue:
Total revenue		$ 486,495	$ 413,081	$ 920,104	$ 791,598
Cost of revenue:
Total cost of revenue		86,805	79,969	169,300	161,415
Gross profit		399,690	333,112	750,804	630,183
Operating expenses:
Sales and marketing		229,788	241,726	466,010	491,852
Research and development		142,301	141,870	291,744	286,397
General and administrative		84,109	44,291	130,213	84,319
Total operating expenses		456,198	427,887	887,967	862,568
Loss from operations		(56,508)	(94,775)	(137,163)	(232,385)
Other expense, net		(10,112)	(15,332)	(23,528)	(293,881)
Loss before provision for income taxes		(66,620)	(110,107)	(160,691)	(526,266)
Provision for income taxes		4,170	5,309	9,613	9,356
Net loss		$ (70,790)	$ (115,416)	$ (170,304)	$ (535,622)
Net loss per share attributable to Class A common stockholders-basic	[1]	$ (0.31)	$ (0.53)	$ (0.74)	$ (2.47)
Net loss per share attributable to Class A common stockholders-diluted	[1]	$ (0.31)	$ (0.53)	$ (0.74)	$ (2.47)
Weighted average shares used in computing net loss per share attributable to Class A common stockholders-basic	[1]	231,924	218,808	230,229	217,153
Weighted average shares used in computing net loss per share attributable to Class A common stockholders-diluted	[1]	231,924	218,808	230,229	217,153
Product
Revenue:
Total revenue		$ 250,538	$ 209,151	$ 459,112	$ 389,256
Cost of revenue:
Total cost of revenue		15,506	15,096	28,022	29,317
Support, Entitlements and Other Services
Revenue:
Total revenue		235,957	203,930	460,992	402,342
Cost of revenue:
Total cost of revenue		$ 71,299	$ 64,873	$ 141,278	$ 132,098
[1] Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 9 for further details.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (70,790)	$ (115,416)	$ (170,304)	$ (535,622)
Other comprehensive loss, net of tax:
Change in unrealized loss on available-for-sale securities, net of tax	3,917	(1,776)	275	(2,427)
Comprehensive loss	$ (66,873)	$ (117,192)	$ (170,029)	$ (538,049)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Stockholders' equity, beginning balance at Jul. 31, 2021	$ (1,020,969)	$ 5	$ 2,615,317	$ (8)	$ (3,636,283)
Stockholders' equity, beginning balance (ASU 2020-06) at Jul. 31, 2021	(48,013)		(148,598)		100,585
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2021		214,210,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
2026 Notes derivative liability reclassification	698,213		698,213
Issuance of common stock through employee equity incentive plans	1,352		1,352
Issuance of common stock through employee equity incentive plans (in shares)		2,809,000
Issuance of common stock from ESPP purchase	28,786		28,786
Issuance of common stock from ESPP purchase (in shares)		1,309,000
Repurchase and retirement of common stock	(58,570)		(14,852)		(43,718)
Repurchase and retirement of common stock (in shares)		(1,369,000)
Unwinding of 2023 Notes hedges	39,880		39,880
Unwinding of 2023 Notes warrants	(18,390)		(18,390)
Stock-based compensation	90,547		90,547
Other comprehensive income	(651)			(651)
Net loss	(420,206)				(420,206)
Stockholders' equity, ending balance at Oct. 31, 2021	(708,021)	$ 5	3,292,255	(659)	(3,999,622)
Stockholders' equity, ending balance (in shares) at Oct. 31, 2021		216,959,000
Stockholders' equity, beginning balance at Jul. 31, 2021	(1,020,969)	$ 5	2,615,317	(8)	(3,636,283)
Stockholders' equity, beginning balance (ASU 2020-06) at Jul. 31, 2021	(48,013)		(148,598)		100,585
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2021		214,210,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(535,622)
Stockholders' equity, ending balance at Jan. 31, 2022	(735,254)	$ 5	3,382,214	(2,435)	(4,115,038)
Stockholders' equity, ending balance (in shares) at Jan. 31, 2022		220,539,000
Stockholders' equity, beginning balance at Oct. 31, 2021	(708,021)	$ 5	3,292,255	(659)	(3,999,622)
Stockholders' equity, beginning balance (in shares) at Oct. 31, 2021		216,959,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	1,914		1,914
Issuance of common stock through employee equity incentive plans (in shares)		3,580,000
Stock-based compensation	88,045		88,045
Other comprehensive income	(1,776)			(1,776)
Net loss	(115,416)				(115,416)
Stockholders' equity, ending balance at Jan. 31, 2022	(735,254)	$ 5	3,382,214	(2,435)	(4,115,038)
Stockholders' equity, ending balance (in shares) at Jan. 31, 2022		220,539,000
Stockholders' equity, beginning balance at Jul. 31, 2022	(800,504)	$ 6	3,583,928	(6,076)	(4,378,362)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2022		226,938,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans	1,975		1,975
Issuance of common stock through employee equity incentive plans (in shares)		2,172,000
Issuance of common stock from ESPP purchase	18,947		18,947
Issuance of common stock from ESPP purchase (in shares)		998,000
Stock-based compensation	80,955		80,955
Other comprehensive income	(3,642)			(3,642)
Net loss	(99,514)				(99,514)
Stockholders' equity, ending balance at Oct. 31, 2022	(801,783)	$ 6	3,685,805	(9,718)	(4,477,876)
Stockholders' equity, ending balance (in shares) at Oct. 31, 2022		230,108,000
Stockholders' equity, beginning balance at Jul. 31, 2022	(800,504)	$ 6	3,583,928	(6,076)	(4,378,362)
Stockholders' equity, beginning balance (in shares) at Jul. 31, 2022		226,938,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(170,304)
Stockholders' equity, ending balance at Jan. 31, 2023	(782,682)	$ 6	3,771,779	(5,801)	(4,548,666)
Stockholders' equity, ending balance (in shares) at Jan. 31, 2023		233,591,000
Stockholders' equity, beginning balance at Oct. 31, 2022	(801,783)	$ 6	3,685,805	(9,718)	(4,477,876)
Stockholders' equity, beginning balance (in shares) at Oct. 31, 2022		230,108,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock through employee equity incentive plans		$ 684	684
Issuance of common stock through employee equity incentive plans (in shares)		3,483,000
Stock-based compensation		$ 85,290	85,290
Other comprehensive income		3,917		3,917
Net loss	(70,790)	(70,790)			(70,790)
Stockholders' equity, ending balance at Jan. 31, 2023	$ (782,682)	$ 6	$ 3,771,779	$ (5,801)	$ (4,548,666)
Stockholders' equity, ending balance (in shares) at Jan. 31, 2023		233,591,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		3 Months Ended				6 Months Ended		12 Months Ended
		Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Cash flows from operating activities:
Net loss		$ (70,790)	$ (99,514)	$ (115,416)	$ (420,206)	$ (170,304)	$ (535,622)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization						39,479	45,582
Stock-based compensation						166,245	178,592
Change in fair value of derivative liability						0	198,038
Loss on debt extinguishment						0	64,910
Amortization of debt discount and issuance costs						21,082	19,796
Operating lease cost, net of accretion						18,158	18,336
Early exit of lease-related assets						(1,109)	0
Non-cash interest expense						9,817	9,575
Other						(2,427)	5,156
Changes in operating assets and liabilities:
Accounts receivable, net						(28,649)	23,826
Deferred commissions						19,110	(13,332)
Prepaid expenses and other assets						(28,348)	(4,951)
Accounts payable						(3,171)	(2,391)
Accrued compensation and benefits						(11,467)	(19,496)
Accrued expenses and other liabilities						52,423	(2,662)
Operating leases, net						(19,965)	(23,619)
Deferred revenue						78,723	70,968
Net cash (used in) provided by operating activities						139,597	32,706
Cash flows from investing activities:
Maturities of investments						529,112	568,697
Purchases of investments						(508,984)	(556,148)
Sales of investments						0	17,999
Purchases of property and equipment						(30,772)	(17,390)
Net cash used in investing activities						(10,644)	13,158
Cash flows from financing activities:
Repayment of convertible notes						(145,704)	0
Payments of debt extinguishment costs						0	(14,709)
Proceeds from unwinding of convertible note hedges						0	39,880
Payments for unwinding of warrants						0	(18,390)
Proceeds from sales of shares through employee equity incentive plans						22,896	32,053
Proceeds from the issuance of convertible notes, net of issuance costs						0	89,128
Repurchases of common stock						0	(58,570)
Payment of finance lease obligations						(2,344)	(323)
Net cash provided by (used in) financing activities						(125,152)	69,069
Net (decrease) increase in cash, cash equivalents and restricted cash						3,801	114,933
Cash, cash equivalents and restricted cash—beginning of period			$ 405,862		$ 288,873	405,862	288,873	$ 288,873
Cash, cash equivalents and restricted cash—end of period		409,663		403,806		409,663	403,806	405,862
Restricted cash	[1]	3,062		3,057		3,062	3,057
Cash and cash equivalents—end of period		$ 406,601		$ 400,749		406,601	400,749	$ 402,850
Supplemental disclosures of cash flow information:
Cash paid for income taxes						16,191	12,084
Supplemental disclosures of non-cash investing and financing information:
Purchases of property and equipment included in accounts payable and accrued and other liabilities						18,646	18,939
Finance lease liabilities arising from obtaining right-of-use assets						9,567	11,148
Convertible senior notes offering costs included in accrued liabilities						$ 0	$ 693
[1] Included within other assets—non-current in the condensed consolidated balance sheets.

Overview and Basis of Presentat

Overview and Basis of Presentation	6 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Overview and Basis of Presentation	NOTE 1. OVERVIEW AND B ASIS OF PRESENTATION Organization and Description of Business Nutanix, Inc. was incorporated in the state of Delaware in September 2009. Nutanix, Inc. is headquartered in San Jose, California, and together with its wholly-owned subsidiaries (collectively, "we," "us," "our" or "Nutanix"), has operations throughout North America, Europe, Asia Pacific, the Middle East, Latin America, and Africa. We provide a leading enterprise cloud platform, which we call the Nutanix Cloud Platform, that consists of software solutions and cloud services that power our customers’ enterprise infrastructure. Our solutions deliver a consistent cloud operating model across edge, private-, hybrid- and multicloud environments for all applications and their data. Our solutions allow organizations to simply move their workloads, including enterprise applications, high-performance databases, end-user computing and virtual desktop infrastructure ("VDI") services, container-based modern applications, and analytics applications, between on-premises and public clouds. Our solutions are primarily sold through channel partners and original equipment manufacturers ("OEMs") (collectively, "Partners"), and delivered directly to our end customers. Principles of Consolidation and Significant Accounting Policies The accompanying condensed consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") and are consistent in all material respects with those included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022, filed with the Securities and Exchange Commission ("SEC") on September 21, 2022. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited, but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. The consolidated balance sheet as of July 31, 2022 is derived from audited financial statements; however, it does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022 . Use of Estimates The preparation of interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; warranty liability; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the 2.50 % convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Concentration of Risk Concentration of revenue and accounts receivable —We sell our products primarily through our Partners and occasionally directly to end customers. For the three and six months ended January 31, 2022 and 2023 , no end customer accounted for more than 10 % of total revenue or accounts receivable, except for one end customer that accounted for 24 % of the accounts receivable balance as of January 31, 2023. For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Three Months Ended Six Months Ended July 31, January 31, Partners 2022 2023 2022 2023 Partner A 14 % 12 % 14 % 15 % 11 % 16 % Partner B 34 % 33 % 33 % 32 % 26 % 12 % Partner C (1) (1) (1) (1) (1) 10 % Partner D (1) 10 % 11 % 11 % (1) (1) (1) Less than 10% Summary of Significant Accounting Policies There have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022 , filed with the SEC on September 21, 2022, that have had a material impact on our condensed consolidated financial statements.

REVISION TO PRIOR PERIOD FINANC

REVISION TO PRIOR PERIOD FINANCIAL STATEMENT	6 Months Ended
	Jan. 31, 2023
Prior Period Adjustment [Abstract]
CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENT	NOTE 2. CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENTS In connection with the Audit Committee investigation and subsequent to the issuance of the condensed consolidated financial statements for the fiscal quarter ended October 31, 2022, we discovered an error in the reporting of expenses for software licenses and support for each prior period beginning in August 2014, resulting in an immaterial understatement of operating expenses and accrued expenses and other current liabilities for these prior periods. We have evaluated the materiality of this error and determined that the impact is not material to our previously issued financial statements. We have determined to prospectively correct our previously issued financial statements to reflect the correction of this error rather than record a cumulative out-of-period adjustment for this error in the current period. As a result, we have corrected the accompanying condensed consolidated financial statements as of July 31, 2022 and for the three and six months ended January 31, 2022, from amounts previously reported to reflect the correction of this error. The correction reflects our estimates of future payments for past non-compliant use of third-party software. Actual amounts may vary materially from these estimates. The following tables summarize the effects of the correction: As of July 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Balance Sheet: Accrued expenses and other current liabilities $ 49,232 $ 10,336 $ 59,568 Total current liabilities $ 1,150,224 $ 10,336 $ 1,160,560 Total liabilities $ 3,155,917 $ 10,336 $ 3,166,253 Accumulated deficit $ ( 4,368,026 ) $ ( 10,336 ) $ ( 4,378,362 ) Total stockholders’ deficit $ ( 790,168 ) $ ( 10,336 ) $ ( 800,504 ) Three Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Operations: Sales and marketing $ 241,633 $ 93 $ 241,726 Research and development $ 141,608 $ 262 $ 141,870 Total operating expenses $ 427,532 $ 355 $ 427,887 Loss from operations $ ( 94,420 ) $ ( 355 ) $ ( 94,775 ) Loss before provision for income taxes $ ( 109,752 ) $ ( 355 ) $ ( 110,107 ) Net loss $ ( 115,061 ) $ ( 355 ) $ ( 115,416 ) Net loss per share attributable to Class A and Class $ ( 0.53 ) $ ( 0.00 ) $ ( 0.53 ) Six Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Operations: Sales and marketing $ 491,666 $ 186 $ 491,852 Research and development $ 285,874 $ 523 $ 286,397 Total operating expenses $ 861,859 $ 709 $ 862,568 Loss from operations $ ( 231,676 ) $ ( 709 ) $ ( 232,385 ) Loss before provision for income taxes $ ( 525,557 ) $ ( 709 ) $ ( 526,266 ) Net loss $ ( 534,913 ) $ ( 709 ) $ ( 535,622 ) Net loss per share attributable to Class A and Class $ ( 2.46 ) $ ( 0.01 ) $ ( 2.47 ) Three Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Comprehensive Loss: Net loss $ ( 115,061 ) $ ( 355 ) $ ( 115,416 ) Comprehensive loss $ ( 116,837 ) $ ( 355 ) $ ( 117,192 ) Six Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Comprehensive Loss: Net loss $ ( 534,913 ) $ ( 709 ) $ ( 535,622 ) Comprehensive loss $ ( 537,340 ) $ ( 709 ) $ ( 538,049 ) As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Stockholders' Deficit: Accumulated Deficit as of: July 31, 2021 $ ( 3,627,355 ) $ ( 8,928 ) $ ( 3,636,283 ) October 31, 2021 $ ( 3,990,340 ) $ ( 9,282 ) $ ( 3,999,622 ) January 31, 2022 $ ( 4,105,401 ) $ ( 9,637 ) $ ( 4,115,038 ) July 31, 2022 $ ( 4,368,026 ) $ ( 10,336 ) $ ( 4,378,362 ) October 31, 2022 $ ( 4,467,142 ) $ ( 10,734 ) $ ( 4,477,876 ) Total Stockholders' Deficit as of: July 31, 2021 $ ( 1,012,041 ) $ ( 8,928 ) $ ( 1,020,969 ) October 31, 2021 $ ( 698,739 ) $ ( 9,282 ) $ ( 708,021 ) January 31, 2022 $ ( 725,617 ) $ ( 9,637 ) $ ( 735,254 ) July 31, 2022 $ ( 790,168 ) $ ( 10,336 ) $ ( 800,504 ) October 31, 2022 $ ( 791,049 ) $ ( 10,734 ) $ ( 801,783 ) Net Loss for the Three Months Ended: October 31, 2021 $ ( 419,852 ) $ ( 354 ) $ ( 420,206 ) January 31, 2022 $ ( 115,061 ) $ ( 355 ) $ ( 115,416 ) October 31, 2022 $ ( 99,116 ) $ ( 398 ) $ ( 99,514 ) Six Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Cash Flows: Net loss $ ( 534,913 ) $ ( 709 ) $ ( 535,622 ) Accrued expenses and other liabilities $ ( 3,371 ) $ 709 $ ( 2,662 )

Revenue, Deferred Revenue and D

Revenue, Deferred Revenue and Deferred Commissions	6 Months Ended
	Jan. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]
Revenue, Deferred Revenue and Deferred Commissions	NOTE 3. REVENUE, DEFERRED REV ENUE AND DEFERRED COMMISSIONS Disaggregation of Revenue and Revenue Recognition We generate revenue primarily from the sale of our enterprise cloud platform, which can be delivered pre-installed on an appliance that is configured to order or delivered separately to be utilized on a variety of certified hardware platforms. When the software license is not portable to other appliances, it can be used over the life of the associated appliance, while subscription term-based licenses typically have a term of one to five year s. Configured-to-order appliances, including our Nutanix-branded NX hardware line, can be purchased from one of our OEMs or in limited cases, directly from Nutanix. Our enterprise cloud platform typically includes one or more years of support and entitlements, which provides customers with the right to software upgrades and enhancements as well as technical support. A substantial portion of sales are made through channel partners and OEM relationships. The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Subscription $ 374,744 $ 450,948 $ 712,645 $ 853,872 Non-portable software 14,542 10,875 28,879 18,658 Hardware 1,753 1,230 3,916 1,854 Professional services 22,042 23,442 46,158 45,720 Total revenue $ 413,081 $ 486,495 $ 791,598 $ 920,104 Subscription revenue — Subscription revenue includes any performance obligation which has a defined term and is generated from the sales of software entitlement and support subscriptions, subscription software licenses and cloud-based software as a service ("SaaS") offerings. • Ratable — We recognize revenue from software entitlement and support subscriptions and SaaS offerings ratably over the contractual service period, the substantial majority of which relate to software entitlement and support subscriptions. These offerings represented approximately $ 191.3 million and $ 374.5 million of our subscription revenue for the three and six months ended January 31, 2022, respectively, and $ 224.2 million and $ 437.6 million of our subscription revenue for the three and six months ended January 31, 2023, respectively. • Upfront — Revenue from our subscription software licenses is generally recognized upfront upon transfer of control to the customer, which happens when we make the software available to the customer. These subscription software licenses represented approximately $ 183.4 million and $ 338.1 million of our subscription revenue for the three and six months ended January 31, 2022, respectively, and $ 226.7 million and $ 416.3 million of our subscription revenue for the three and six months ended January 31, 2023, respectively. Non-portable software revenue — Non-portable software revenue includes sales of our enterprise cloud platform when delivered on a configured-to-order appliance by us or one of our OEM partners. The software licenses associated with these sales are typically non-portable and can be used over the life of the appliance on which the software is delivered. Revenue from our non-portable software products is generally recognized upon transfer of control to the customer. Hardware revenue — In transactions where the hardware appliance is purchased directly from Nutanix, we consider ourselves to be the principal in the transaction and we record revenue and costs of goods sold on a gross basis. We consider the amount allocated to hardware revenue to be equivalent to the cost of the hardware procured. Hardware revenue is generally recognized upon transfer of control to the customer. Professional services revenue — We also sell professional services with our products. We recognize revenue related to professional services as they are performed. Contracts with multiple performance obligations — The majority of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price ("SSP") basis. For deliverables that we routinely sell separately, such as software entitlement and support subscriptions on our core offerings, we determine SSP by evaluating the standalone sales over the trailing 12 months. For those that are not sold routinely, we determine SSP based on our overall pricing trends and objectives, taking into consideration market conditions and other factors, including the value of our contracts, the products sold and geographic locations. Contract balances — The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period in which we deliver goods or provide services, or when our right to consideration is unconditional. In situations where revenue recognition occurs before invoicing, an unbilled receivable is created, which represents a contract asset. Unbilled accounts receivable, included in accounts receivable, net on the condensed consolidated balance sheets, was not material for any of the periods presented. Payment terms on invoiced amounts are typically 30-45 days. We assess credit losses on accounts receivable by taking into consideration past collection experience, the credit quality of the customer, the age of the receivable balance, current and future economic conditions, and forecasts that may affect the collectibility of the reported amount. The balance of accounts receivable, net of allowance for credit losses, as of July 31, 2022 and January 31, 2023 is presented in the accompanying condensed consolidated balance sheets. Costs to obtain and fulfill a contract — We capitalize commissions paid to sales personnel and the related payroll taxes when customer contracts are signed. These costs are recorded as deferred commissions in the condensed consolidated balance sheets, current and non-current. We determine whether costs should be deferred based on our sales compensation plans, if the commissions are incremental and would not have been incurred absent the execution of the customer contract. Commissions paid upon the initial acquisition of a contract are recognized over the estimated period of benefit, which may exceed the term of the initial contract if the commissions expected to be paid upon renewal are not commensurate with that of the initial contract. Accordingly, deferred costs are recognized on a systematic basis that is consistent with the pattern of revenue recognition allocated to each performance obligation over the entire period of benefit and included in sales and marketing expense in the condensed consolidated statements of operations. We determine the estimated period of benefit by evaluating the expected renewals of customer contracts, the duration of relationships with our customers, customer retention data, our technology development lifecycle and other factors. Deferred costs are periodically reviewed for impairment. Taxes assessed by a government authority that are both imposed on and concurrent with specific revenue transactions between us and our customers are presented on a net basis in our condensed consolidated statements of operations. Deferred revenue — Deferred revenue primarily consists of amounts that have been invoiced but not yet recognized as revenue and primarily pertain to software entitlement and support subscriptions and professional services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the condensed consolidated balance sheet date. Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows: Deferred Deferred (in thousands) Balance as of July 31, 2022 $ 1,445,538 $ 367,590 Additions (1) 469,647 33,112 Revenue/commissions recognized ( 433,609 ) ( 48,325 ) Balance as of October 31, 2022 1,481,576 352,377 Additions (1) 531,230 46,439 Revenue/commissions recognized ( 486,495 ) ( 50,336 ) Balance as of January 31, 2023 $ 1,526,311 $ 348,480 (1) Includes both billed and unbilled amounts. During the three and six months ended January 31, 2022 , we recognized revenue of approximately $ 186.9 million and $ 342.8 million pertaining to amounts deferred as of October 31, 2021 and July 31, 2021, respectively. During the three and six months ended January 31, 2023 , we recognized revenue of approximately $ 219.9 million and $ 399.3 million pertaining to amounts deferred as of October 31, 2022 and July 31, 2022, respectively. Many of our contracted but not invoiced performance obligations are subject to cancellation terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized ("contracted not recognized"), which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenue in future periods and excludes performance obligations that are subject to cancellation terms. Contracted not recognized revenue was approximately $ 1.6 billion as of January 31, 2023 , of which we expect to recognize approximately 53 % over the next 12 months, and the remainder thereafter.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 4. FAIR VAL UE MEASUREMENTS The fair value of our financial assets measured on a recurring basis is as follows: As of July 31, 2022 Level I Level II Level III Total (in thousands) Financial Assets: Cash equivalents: Money market funds $ 227,796 $ — $ — $ 227,796 Commercial paper — 27,927 — 27,927 Short-term investments: Corporate bonds — 409,024 — 409,024 Commercial paper — 317,738 — 317,738 U.S. Government securities — 194,667 — 194,667 Total measured at fair value $ 227,796 $ 949,356 $ — $ 1,177,152 Cash 147,127 Total cash, cash equivalents and short-term investments $ 1,324,279 As of January 31, 2023 Level I Level II Level III Total (in thousands) Financial Assets: Cash equivalents: Money market funds $ 236,317 $ — $ — $ 236,317 U.S. Government securities — 2,979 — 2,979 Commercial paper — 27,928 — 27,928 Short-term investments: Corporate bonds — 467,686 — 467,686 Commercial paper — 235,575 — 235,575 U.S. Government securities — 201,502 — 201,502 Total measured at fair value $ 236,317 $ 935,670 $ — $ 1,171,987 Cash 139,377 Total cash, cash equivalents and short-term investments $ 1,311,364 Financial Instruments Not Recorded at Fair Value on a Recurring Basis We report our financial instruments at fair value, with the exception of the 0% convertible senior notes due 2023 (the "2023 Notes"), the 2026 Notes and the 0.25 % convertible senior notes due 2027 (the "2027 Notes") (collectively, the "Notes"). Financial instruments that are not recorded at fair value on a recurring basis are measured at fair value on a quarterly basis for disclosure purposes. The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: As of July 31, 2022 As of January 31, 2023 Carrying Estimated Carrying Estimated (in thousands) 2023 Notes $ 145,456 $ 143,154 $ — $ — 2026 Notes 589,200 759,086 618,995 973,154 2027 Notes 567,005 400,252 567,769 501,095 Total $ 1,301,661 $ 1,302,492 $ 1,186,764 $ 1,474,249 The carrying value of the 2023 Notes as of July 31, 2022 was net of unamortized debt issuance costs of $ 0.2 million. In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $ 145.7 million. The carrying value of the 2026 Notes as of July 31, 2022 and January 31, 2023 included $ 28.0 million and $ 37.7 million, respectively, of non-cash interest expense that was converted to the principal balance, net of unamortized debt discounts of $ 169.4 million and $ 151.4 million, respectively, and unamortized debt issuance costs of $ 19.4 million and $ 17.3 million, respectively. The carrying value of the 2027 Notes as of July 31, 2022 and January 31, 2023 was net of unamortized debt issuance costs of $ 8.0 million and $ 7.2 million, respectively. The total estimated fair value of the 2023 Notes was determined based on the closing trading price per $ 100 of the 2023 Notes as of the last day of trading for the period. We consider the fair value of the 2023 Notes to be a Level 2 valuation due to the limited trading activity. The total estimated fair value of the 2026 Notes is based on a binomial model. We consider the fair value of the 2026 Notes to be a Level 3 valuation, as the 2026 Notes are not publicly traded. The Level 3 inputs used are the same as those used to determine the estimated fair value of the associated derivative liability, as detailed below. The total estimated fair value of the 2027 Notes was determined based on the closing trading price per $ 100 of the 2027 Notes as of the last day of trading for the period. We consider the fair value of the 2027 Notes to be a Level 2 valuation due to the limited trading activity. Derivative Liability The conversion feature of the 2026 Notes represented an embedded derivative at inception. The 2026 Notes are not considered to be conventional debt and we determined that the embedded conversion feature was required to be bifurcated from the host debt and accounted for as a derivative liability, as the 2026 Notes were convertible into a variable number of shares until the conversion price became fixed in September 2021, based on the level of achievement of the associated financial performance metric. As such, the initial fair value of the derivative instrument was recorded as a liability in the condensed consolidated balance sheet with the corresponding amount recorded as a discount to the 2026 Notes upon issuance. The derivative liability is considered a Level 3 valuation and was recorded at its estimated fair value at the end of each reporting period and as of September 15, 2021, when the conversion price became fixed, with the change in fair value recognized within other expense, net in the condensed consolidated statements of operations. On September 15, 2021, the conversion price of the 2026 Notes became fixed and the bifurcated liability was no longer accounted for as a separate derivative because the conversion features are now considered indexed to our own equity and meet the equity classification conditions. We estimated the fair value of the derivative liability as of September 15, 2021 to be $ 698.2 million, which was reclassified to equity on that date.

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	NOTE 5. BALANCE SHEET COMPONENTS Short-Term Investments The amortized cost of our short-term investments approximates their fair value. Unrealized losses related to our short-term investments are generally due to interest rate fluctuations, as opposed to credit quality. However, we review individual securities that are in an unrealized loss position in order to evaluate whether or not they have experienced or are expected to experience credit losses that would result in a decline in fair value. As of July 31, 2022 and January 31, 2023, unrealized gains and losses from our short-term investments were not material and were not the result of a decline in credit quality. As a result, as of July 31, 2022 and January 31, 2023, we did not record any credit losses for these investments. The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates: As of (in thousands) Due within one year $ 675,573 Due in one to two years 229,190 Total $ 904,763 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consists of the following: As of July 31, January 31, (in thousands) Prepaid operating expenses $ 48,842 $ 52,495 VAT receivables 7,514 5,919 Other current assets 37,431 57,349 Total prepaid expenses and other current assets $ 93,787 $ 115,763 The increase in prepaid expenses and other current assets from July 31, 2022 to January 31, 2023 was due primarily to the insurance receivable related to our securities class action lawsuit. For additional details on this legal proceeding, refer to Note 8. Property and Equipment, Net Property and equipment, net consists of the following: As of Estimated July 31, January 31, (in months) (in thousands) Computer, production, engineering and other equipment 36 $ 341,536 $ 365,480 Demonstration units 12 61,914 62,474 Leasehold improvements (1) 61,443 63,174 Furniture and fixtures 60 16,508 16,237 Total property and equipment, gross 481,401 507,365 Less: accumulated depreciation ( 367,961 ) ( 394,781 ) Total property and equipment, net $ 113,440 $ 112,584 (1) Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. Depreciation expense related to our property and equipment was $ 17.7 million and $ 36.4 million for the three and six months ended January 31, 2022 , respectively, and $ 15.8 million and $ 31.8 million for the three and six months ended January 31, 2023, respectively. Goodwill and Intangible Assets, Net There was no change in the carrying value of goodwill during the six months ended January 31, 2023. Intangible assets, net consists of the following: As of July 31, January 31, (in thousands) Developed technology $ 79,300 $ 79,300 Customer relationships 8,860 8,860 Trade name 4,170 4,170 Total intangible assets, gross 92,330 92,330 Less: Accumulated amortization of developed technology ( 64,344 ) ( 69,684 ) Accumulated amortization of customer relationships ( 8,074 ) ( 8,535 ) Accumulated amortization of trade name ( 4,083 ) ( 4,170 ) Total accumulated amortization ( 76,501 ) ( 82,389 ) Total intangible assets, net $ 15,829 $ 9,941 Amortization expense related to our intangible assets is being recognized in the condensed consolidated statements of operations within product cost of revenue for developed technology and sales and marketing expense for customer relationships and trade name. The estimated future amortization expense of our intangible assets is as follows: Fiscal Year Ending July 31: Amount (in thousands) 2023 (remaining six months) $ 4,968 2024 3,210 2025 1,763 Total $ 9,941 Accrued Compensation and Benefits Accrued compensation and benefits consists of the following: As of July 31, January 31, (in thousands) Contributions to ESPP withheld $ 19,174 $ 26,067 Accrued commissions 32,886 24,400 Accrued vacation 23,140 23,144 Payroll taxes payable 21,060 16,751 Accrued wages and taxes 20,807 13,809 Accrued benefits 11,774 12,914 Accrued bonus 9,782 11,175 Other 11,188 10,083 Total accrued compensation and benefits $ 149,811 $ 138,343 Accrued expenses and other current liabilities consists of the following: As of July 31, January 31, (in thousands) Litigation settlement reserves $ 9,750 $ 71,000 Software usage liability 10,336 11,133 Income taxes payable 13,206 5,613 Accrued professional services 5,499 901 Other 20,777 19,611 Total accrued expenses and other current liabilities $ 59,568 $ 108,258 The increase in accrued expenses and other current liabilities from July 31, 2022 to January 31, 2023 was due primarily to an increase in the litigation settlement reserve related to our securities class action lawsuit. For additional details on this legal proceeding, refer to Note 8.

Convertible Senior Notes

Convertible Senior Notes	6 Months Ended
	Jan. 31, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes	NOTE 6. CONVERTI BLE SENIOR NOTES 2023 Notes In January 2018, we issued the 2023 Notes with a 0 % interest rate for an aggregate principal amount of $ 575.0 million, due in 2023, in a private placement to qualified institutional buyers pursuant to Rule144A under the Securities Act. On September 22, 2021, we consummated privately negotiated exchanges with certain holders of the outstanding 2023 Notes, pursuant to which such holders exchanged approximately $ 416.5 million in aggregate principal amount of 2023 Notes for $ 477.3 million in aggregate principal amount of 2027 Notes. We also entered into privately negotiated transactions with certain holders of the 2023 Notes pursuant to which we repurchased approximately $ 12.8 million in aggregate principal amount of 2023 Notes for cash. Following the closing of these exchanges and repurchases, approximately $ 145.7 million in aggregate principal amount of 2023 Notes remained outstanding with terms unchanged. In January 2023, we settled the 2023 Notes in full at maturity with a cash payment of $ 145.7 million. The 2023 Notes consisted of the following: As of July 31, January 31, (in thousands) Principal amounts: Principal $ 145,704 $ 145,704 Unamortized debt issuance costs (1) ( 248 ) — Repayment of convertible senior notes — ( 145,704 ) Net carrying amount $ 145,456 $ — (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. The effective interest rate was 0.41 %. The following table sets forth the total interest expense recognized related to the 2023 Notes: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Interest expense related to amortization of debt $ 148 $ 99 $ 548 $ 248 Note Hedges and Warrants Concurrently with the offering of the 2023 Notes in January 2018, we entered into convertible note hedge transactions with certain bank counterparties, whereby we have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a conversion price of approximately $ 48.85 per share, subject to adjustment for certain specified events. The total cost of the convertible note hedge transactions was approximately $ 143.2 million. In addition, we sold warrants to certain bank counterparties, whereby the holders of the warrants have the initial option to purchase a total of approximately 11.8 million shares of our Class A common stock at a price of $ 73.46 per share, subject to adjustment for certain specified events. We received approximately $ 88.0 million in cash proceeds from the sale of these warrants. In September 2021, in connection with the exchange and repurchase transactions described above, we terminated portions of the convertible note hedge transactions and warrant transactions previously entered into with certain financial institutions in connection with the issuance of the 2023 Notes. The net effect of these unwind transactions was a $ 21.5 million cash payment received, consisting of an $ 18.4 million payment for the warrant unwind and the receipt of $ 39.9 million from the hedge unwind. The amounts paid and received as part of the unwind transactions were recorded to additional paid-in capital within the condensed consolidated balance sheet. In January 2023, the convertible note hedges and warrant transactions expired concurrently with the expiration of the 2023 Notes. No settlement is required as the stock has remained below the strike price throughout the unwind settlement averaging period. 2026 Notes In September 2020, we issued $ 750.0 million in aggregate principal amount of the 2026 Notes to BCPE Nucleon (DE) SPV, LP, an entity affiliated with Bain Capital, LP ("Bain"). The total net proceeds from this offering were approximately $ 723.7 million, after deducting $ 26.3 million of debt issuance costs. The 2026 Notes bear interest at a rate of 2.5 % per annum, with such interest to be paid in kind ("PIK") on the 2026 Notes held by Bain through an increase in the principal amount of the 2026 Notes, and paid in cash on any 2026 Notes transferred to entities that are not affiliated with Bain. Interest on the 2026 Notes has accrued from the date of issuance, September 24, 2020, and is added to the principal amount, in the case of the 2026 Notes held by Bain, or paid in cash, in the case of the 2026 Notes held by entities that are not affiliated with Bain, as applicable, on a semi-annual basis (on March 15 and September 15 of each year). The 2026 Notes mature on September 15, 2026, subject to earlier conversion, redemption or repurchase. The 2026 Notes are convertible at an initial conversion rate of 36.036 shares of Class A common stock per $ 1,000 principal amount of the 2026 Notes, which is equal to an initial conversion price of $ 27.75 per share, subject to customary anti-dilution and other adjustments, including in connection with any make-whole adjustments as a result of certain extraordinary transactions. In September 2021, the one-year anniversary of the issuance of the 2026 Notes, the conversion price was subject to a one-time adjustment, based on the level of achievement of certain financial milestones and as a result, the conversion price became fixed at $ 27.75 per share. For each $ 1,000 principal amount of 2026 Notes a holder elects to convert, we have initially elected to pay cash with respect to the first $ 1,000 of conversion value and deliver shares of Class A common stock with respect to any conversion value in excess of $ 1,000 . Pursuant to the indenture governing the 2026 Notes, we may elect to change such default settlement method with respect to any conversion of 2026 Notes held by Bain by delivering written notice to Bain at least five trading days prior to the effective time of such settlement election. Additionally, if Bain elects to convert any 2026 Notes it holds upon our delivery of a notice of redemption, Bain will have the right to elect whether such conversion is settled in cash, shares of our Class A common stock or a combination thereof. On or after September 15, 2025, the 2026 Notes will be redeemable by us, at our option, in the event that the closing sale price of our Class A common stock has been at least 150 % of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide the redemption notice, for cash, at a redemption price of 100 % of the principal amount of such 2026 Notes, plus any accrued and unpaid interest to, but excluding, the redemption date. A holder who converts their 2026 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2026 Notes) is, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2026 Notes) prior to the maturity date, holders of the 2026 Notes may require us to repurchase for cash all or a portion of their 2026 Notes at a repurchase price equal to 100 % of the principal amount of the repurchased 2026 Notes, plus accrued and unpaid interest thereon. In accordance with accounting guidance on embedded conversion features, we valued and bifurcated the conversion option associated with the 2026 Notes from the respective host debt instrument, which is treated as a debt discount, and initially recorded the conversion option of $ 230.9 million as a derivative liability in our condensed consolidated balance sheet, with the corresponding amount recorded as a discount to the 2026 Notes to be amortized over the term of the 2026 Notes using the effective interest method. The 2026 Notes consisted of the following: As of July 31, January 31, (in thousands) Principal amounts: Principal $ 750,000 $ 750,000 Non-cash interest expense converted to principal 27,997 37,722 Unamortized debt discount (conversion feature) (1) ( 169,438 ) ( 151,426 ) Unamortized debt issuance costs (1) ( 19,359 ) ( 17,301 ) Net carrying amount $ 589,200 $ 618,995 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %. As of January 31, 2023, the remaining life of the 2026 Notes was approximately 3.6 years . The following table sets forth the total interest expense recognized related to the 2026 Notes: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Interest expense related to amortization of debt $ 8,469 $ 9,085 $ 16,789 $ 18,012 Interest expense related to amortization of debt 968 1,038 1,919 2,058 Non-cash interest expense 4,802 4,923 9,575 9,817 Total interest expense $ 14,239 $ 15,046 $ 28,283 $ 29,887 Non-cash interest expense is related to the 2.5 % PIK interest that we accrued from the issuance of the 2026 Notes through January 31, 2023 and was recognized within other expense, net in the condensed consolidated statement of operations and other liabilities–non-current in the condensed consolidated balance sheet. The accrued PIK interest will be converted to the principal balance of the 2026 Notes at each payment date and will be convertible to shares of our Class A common stock at maturity or when converted. Upon the conversion price of the 2026 Notes becoming fixed, subject to customary anti-dilution and other adjustments, in September 2021, the embedded conversion option for the 2026 Notes no longer required bifurcation because the conversion features are now considered indexed to our own equity and meet the equity classification conditions. The carrying amount of the derivative liability of $ 698.2 million as of that date was reclassified to additional paid-in capital within the condensed consolidated balance sheet. The remaining debt discount that arose from the original bifurcation continues to be amortized over the term of the 2026 Notes. 2027 Notes In September 2021, we issued $ 575 million in aggregate principal amount of 0.25 % convertible senior notes due 2027 consisting of (i) approximately $ 477.3 million principal amount of 2027 Notes in exchange for approximately $ 416.5 million principal amount of the 2023 Notes (the "Exchange Transactions") and (ii) approximately $ 97.7 million principal amount of 2027 Notes for cash (the "Subscription Transactions"). We did not receive any cash proceeds from the Exchange Transactions. The net cash proceeds from the Subscription Transactions was approximately $ 88.4 million after deducting the offering expenses for both the Exchange Transactions and the Subscription Transactions. We used (i) approximately $ 14.7 million of the net cash proceeds from the Subscription Transactions to repurchase approximately $ 12.8 million principal amount of the 2023 Notes and (ii) approximately $ 58.5 million of the net cash proceeds from the Subscription Transactions to repurchase approximately 1.4 million shares of our Class A common stock. The 2027 Notes bear interest at a rate of 0.25 % per annum, and pay interest semi-annually in arrears on each April 1 and October 1. The 2027 Notes will mature on October 1, 2027, unless earlier converted, redeemed or repurchased. The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of Class A common stock, at our election. Each $ 1,000 of principal of the 2027 Notes is initially convertible into 17.3192 shares of our Class A common stock, which is equivalent to an initial conversion price of approximately $ 57.74 per share, subject to customary anti-dilution adjustments. Holders of these 2027 Notes may convert their 2027 Notes at their option at any time prior to the close of the business day immediately preceding July 1, 2027, only under the following circumstances: (1) during any fiscal quarter, and only during such fiscal quarter, if the closing price of our common stock for at least 20 trading days in a period of 30 consecutive trading days ending on, and including, the last trading day of the preceding fiscal quarter is greater than or equal to 130 % of the then applicable conversion price for the Notes per share of common stock; (2) during the five business day period after any five consecutive trading day period in which, for each trading day of that period, the trading price per $ 1,000 principal amount of 2027 Notes for such trading day was less than 98 % of the product of the closing price of our common stock and the then applicable conversion rate on each such trading day; (3) if we call the 2027 Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of certain specified corporate events. Upon conversion of the 2027 Notes, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of Class A common stock, at our election. We intend to settle the principal of the 2027 Notes in cash. The conversion rate will be subject to adjustment in certain events, but will not be adjusted for any accrued or unpaid interest. A holder who converts their 2027 Notes in connection with certain corporate events that constitute a "make-whole fundamental change" (as defined in the indenture governing the 2027 Notes) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, if we undergo a "fundamental change" (as defined in the indenture governing the 2027 Notes) prior to the maturity date, holders of the 2027 Notes may require us to repurchase for cash all or a portion of their 2027 Notes at a repurchase price equal to 100 % of the principal amount of the repurchased 2027 Notes, plus accrued and unpaid interest thereon. In accounting for the exchange of convertible notes, we evaluated whether the transaction should be treated as a modification or extinguishment transaction. The partial exchange of the 2023 Notes and issuance of the 2027 Notes were deemed to have substantially different terms due to the significant difference between the value of the conversion option immediately prior to and after the exchange, and consequently, the 2023 Notes partial exchange was accounted for as a debt extinguishment. The $ 64.9 million difference between the total reacquisition price paid and the net carrying amount of the 2023 Notes is recognized as a debt extinguishment loss within other expense, net in the condensed consolidated statement of operations. The 2027 Notes consisted of the following: As of July 31, January 31, (in thousands) Principal amounts: Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (1) ( 7,995 ) ( 7,231 ) Net carrying amount $ 567,005 $ 567,769 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %. As of January 31, 2023, the remaining life of the 2027 Notes was approximately 4.7 years . The following table sets forth the total interest expense recognized related to the 2027 Notes: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Contractual interest expense $ 359 $ 359 $ 511 $ 718 Interest expense related to amortization of debt 380 382 540 764 Total interest expense $ 739 $ 741 $ 1,051 $ 1,482

Leases

Leases	6 Months Ended
	Jan. 31, 2023
Leases [Abstract]
Leases	NOTE 7. LEASES We have operating leases for offices, research and development facilities and datacenters and finance leases for certain datacenter equipment. Our leases have remaining lease terms of one year to approximately seven years , some of which include options to renew or terminate. We do not include renewal options in the lease terms for calculating our lease liability, as we are not reasonably certain that we will exercise these renewal options at the time of the lease commencement. Our lease agreements do not contain any residual value guarantees or restrictive covenants. Total operating lease cost was $ 10.8 million and $ 21.7 million for the three and six months ended January 31, 2022 , respectively, and $ 11.2 million and $ 21.9 million for the three and six months ended January 31, 2023 , respectively, excluding short-term lease costs, variable lease costs and sublease income, each of which were not material. Variable lease costs primarily include common area maintenance charges. Total finance lease cost was $ 0.6 million and $ 1.1 million for the three and six months ended January 31, 2022 , respectively, and $ 1.1 million and $ 1.8 million for the three and six months ended January 31, 2023, respectively. During the six months ended January 31, 2023, we signed agreements to early exit certain office spaces in the United States and the Netherlands. The reductions in the lease terms resulted in decreases to the carrying amounts of the operating lease liabilities and the operating lease right-of-use assets on our condensed consolidated balance sheet as of January 31, 2023 . In addition, we recorded $ 0.8 million and $ 1.7 million of expense in our condensed consolidated statements of operations for the three and six months ended January 31, 2023, respectively. Supplemental balance sheet information related to leases is as follows: As of July 31, January 31, (in thousands) Operating leases: Operating lease right-of-use assets, gross $ 188,060 $ 191,509 Accumulated amortization ( 69,320 ) ( 84,798 ) Operating lease right-of-use assets, net $ 118,740 $ 106,711 Operating lease liabilities—current $ 39,801 $ 34,101 Operating lease liabilities—non-current 89,782 80,585 Total operating lease liabilities $ 129,583 $ 114,686 Weighted average remaining lease term (in years): 5.1 5.0 Weighted average discount rate: 5.7 % 5.8 % As of July 31, January 31, (in thousands) Finance leases: Finance lease right-of-use assets, gross (1) $ 13,501 $ 12,879 Accumulated amortization (1) ( 3,053 ) ( 3,793 ) Finance lease right-of-use assets , net (1) $ 10,448 $ 9,086 Finance lease liabilities—current (2) $ 2,685 $ 2,525 Finance lease liabilities—non-current (3) 7,806 7,042 Total finance lease liabilities $ 10,491 $ 9,567 Weighted average remaining lease term (in years): 3.9 3.6 Weighted average discount rate: 5.9 % 6.2 % (1) Included in the condensed consolidated balance sheets within property and equipment, net. (2) Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. (3) Included in the condensed consolidated balance sheets within other liabilities—non-current. Supplemental cash flow and other information related to leases is as follows: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Cash paid for amounts included in the measurement of Operating cash flows from operating leases $ 12,081 $ 11,914 $ 25,557 $ 23,763 Financing cash flows from finance leases $ 104 $ 488 $ 323 $ 2,344 Lease liabilities arising from obtaining right-of-use assets: Operating leases $ — $ 4,625 $ 3,950 $ 5,971 Finance leases $ 3,873 $ 1,543 $ 3,873 $ 1,543 The undiscounted cash flows for our operating lease liabilities as of January 31, 2023 were as follows: Fiscal Year Ending July 31: Operating Finance Total (in thousands) 2023 $ 19,718 $ 1,447 $ 21,165 2024 31,266 3,059 34,325 2025 18,341 3,059 21,400 2026 14,698 2,357 17,055 2027 13,463 647 14,110 Thereafter 38,720 116 38,836 Total lease payments 136,206 10,685 146,891 Less: imputed interest ( 21,520 ) ( 1,118 ) ( 22,638 ) Total lease obligation 114,686 9,567 124,253 Less: current lease obligations ( 34,101 ) ( 2,525 ) ( 36,626 ) Long-term lease obligations $ 80,585 $ 7,042 $ 87,627 As of January 31, 2023 , we did not have any additional operating lease commitments for office leases that have not yet commenced.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jan. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 8. COMMITMENTS AND CONTINGENCIES Purchase Commitments In the normal course of business, we make commitments with our contract manufacturers to ensure them a minimum level of financial consideration for their investment in our joint solutions. These commitments are based on performance targets or on-hand inventory and non-cancelable purchase orders for non-standard components. We record a charge related to these items when we determine that it is probable a loss will be incurred and we are able to estimate the amount of the loss. Our historical charges have not been material. As of January 31, 2023, we had up to approximately $ 101.3 million of non-cancelable purchase obligations and other commitments pertaining to our daily business operations, and up to approximately $ 60.3 million in the form of guarantees to certain of our contract manufacturers. Legal Proceedings Securities Class Actions . Beginning on March 29, 2019, several purported securities class actions were filed in the United States District Court for the Northern District of California against us and two of our officers. The initial complaints generally alleged that the defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5. In July 2019, the court consolidated the actions into a single action, and appointed a lead plaintiff, who then filed a consolidated amended complaint (the "Original Complaint"). The action was brought on behalf of those who purchased or otherwise acquired our stock between November 30, 2017 and May 30, 2019, inclusive. The defendants subsequently filed a motion to dismiss the Original Complaint, which the court granted on March 9, 2020, while providing the lead plaintiff leave to amend. On April 17, 2020, the lead plaintiff filed a second amended complaint (the "Amended Complaint"), again naming us and two of our officers as defendants. The Amended Complaint alleges the same class period, includes many of the same factual allegations as the Original Complaint, and again alleges that the defendants violated Sections 10(b) and 20(a) of the Exchange Act, as well as SEC Rule 10b-5. The Amended Complaint sought monetary damages in an unspecified amount. On September 11, 2020, the court denied the defendants' motion to dismiss the Amended Complaint and held that the lead plaintiff adequately stated a claim with respect to certain statements regarding our new customer growth and sales productivity. On January 27, 2021, lead plaintiff, Shimon Hedvat, filed a motion to (i) withdraw as lead plaintiff and (ii) substitute proposed new lead plaintiffs and approve their appointment of a new co-lead counsel. On March 1, 2021, the court granted the lead plaintiff’s motion to withdraw as lead plaintiff but denied without prejudice his motion to substitute proposed new lead plaintiffs. The court also reopened the lead plaintiff selection process, allowing any putative class member interested in serving as the new lead plaintiff to file a lead plaintiff application. Following the lead plaintiff selection hearing on April 28, 2021, on June 10, 2021 the court appointed California Ironworkers Field Pension Trust as lead plaintiff and approved its appointment of counsel. On May 28, 2021, one of the movants for lead plaintiff, John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002, filed a separate class action complaint (the "Options Class Action Complaint") in the Northern District of California on behalf of a class of persons or entities who transacted in publicly traded call options and/or put options on Nutanix stock during the period from November 30, 2017 and May 30, 2019, containing allegations substantively the same as those alleged in the Amended Complaint (the "Options Class Action") and naming the same defendants. On September 8, 2021, the court appointed the John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002 as the lead plaintiff in the Options Class Action. On April 26, 2022, the parties met for mediation, which did not result in a settlement. On September 1, 2022, California Ironworkers Field Pension Trust filed a third amended complaint (which amends the Amended Complaint, the "Third Amended Complaint") and John P. Norton on behalf of the Norton Family Living Trust UAD 11/15/2002 filed an amended complaint (which amends the Options Class Action Complaint, the "First Amended Complaint"). On November 14, 2022, the defendants filed a motion to dismiss the Third Amended Complaint and the First Amended Complaint. On February 9, 2023, the plaintiffs and the defendants agreed to a mediator’s recommendation to settle these actions for a total of $71.0 million, which has been accrued as of January 31, 2023 and is included within accrued expenses and other current liabilities on our condensed consolidated balance sheet. On May 19, 2023, the court granted its preliminary approval of the settlement and the notice to class members, and a final settlement hearing is scheduled for October 4, 2023. The settlement accrual is partially offset by a receivable of $39.9 million for amounts recoverable under our applicable insurance policies, which is included within prepaid expenses and other current assets on our condensed consolidated balance sheet as of January 31, 2023. During the three months ended January 31, 2023, we recorded charges of $38.2 million for the settlement and applicable legal fees, net of our insurance receivable. On April 14, 2023, a purported federal securities class action complaint was filed in the United States District Court for the Northern District of California against us, two of our current officers, and a former officer. The complaint generally alleges that the defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. This action is brought on behalf of those who purchased or otherwise acquired our securities between September 21, 2021 and March 6, 2023, inclusive. In addition, on May 5, 2023, a purported stockholder derivative complaint was filed in the United States District Court for the Northern District of California, naming our current directors as defendants and our company as a nominal defendant. The complaint generally alleges violations of Section 14(a) of the Securities Exchange Act of 1934 and breach of fiduciary duties, and aiding and abetting breach of fiduciary duties, based on similar underlying allegations contained in the purported federal securities class action complaint described above. These cases are in their very early stages, and we are not able to determine what, if any, liabilities will attach to these complaints. We are not currently a party to any other legal proceedings that we believe to be material to our business or financial condition. From time to time, we may become party to various litigation matters and subject to claims that arise in the ordinary course of business.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jan. 31, 2023
Equity [Abstract]
Stockholders' Equity	NOTE 9. STOCKHO LDERS’ EQUITY Effective January 3, 2022, all of our then outstanding shares of Class B common stock, par value $ 0.000025 per share, were automatically converted into the same number of shares of the Company’s Class A common stock, par value $ 0.000025 per share, pursuant to the terms of our Amended and Restated Certificate of Incorporation. No additional shares of Class B common stock will be issued following such conversion. As a result, as of January 31, 2023 , we had one class of outstanding common stock consisting of Class A common stock. In December 2022, our stockholders approved an amendment and restatement of our Amended and Restated Certificate of Incorporation, which includes the removal of all provisions related to Class B common stock. As of January 31, 2023 , we had 1.0 billion shares of Class A common stock authorized, with a par value of $ 0.000025 per share. As of January 31, 2023 , we had 233.6 million shares of Class A common stock issued and outstanding. Holders of Class A common stock are entitled to one vote for each share of Class A common stock held on all matters submitted to a vote of stockholders. In September 2021, we used approximately $ 58.5 million of the net cash proceeds from the issuance of $ 97.7 million in aggregate principal amount of 2027 Notes to repurchase 1.4 million shares of Class A common stock in open market transactions at an average price of $ 42.77 per share. For additional details on these transactions, refer to Note 6.

Equity Incentive Plans

Equity Incentive Plans	6 Months Ended
	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	NOTE 10. EQUITY INCENTIVE PLANS Stock Plans We have three equity incentive plans, the 2010 Stock Plan ("2010 Plan"), 2011 Stock Plan ("2011 Plan") and 2016 Equity Incentive Plan ("2016 Plan"). Our stockholders approved the 2016 Plan in March 2016 and it became effective in connection with our initial public offering ("IPO"). As a result, at the time of the IPO, we ceased granting additional stock awards under the 2010 Plan and 2011 Plan and both plans were terminated. Any outstanding stock awards under the 2010 Plan and 2011 Plan remain outstanding, subject to the terms of the applicable plan and award agreements, until such shares are issued under those stock awards, by exercise of stock options or settlement of restricted stock units ("RSUs"), or until those stock awards become vested or expired by their terms. Under the 2016 Plan, we may grant incentive stock options, non-statutory stock options, restricted stock, RSUs and stock appreciation rights to employees, directors and consultants. We initially reserved 22.4 million shares of our Class A common stock for issuance under the 2016 Plan. The number of shares of Class A common stock available for issuance under the 2016 Plan also includes an annual increase on the first day of each fiscal year, beginning in fiscal 2018, equal to the lesser of: 18.0 million shares, 5 % of the outstanding shares of all classes of common stock as of the last day of our immediately preceding fiscal year, or such other amount as may be determined by the Board. Accordingly, on August 1, 2021 and 2022, the number of shares of Class A common stock available for issuance under the 2016 Plan increased by 10.7 million and 11.3 million shares, respectively, pursuant to these provisions. As of January 31, 2023 , we had reserved a total of 44.7 million shares for the issuance of equity awards under the Stock Plans, of which 13.8 million shares were still available for grant. Restricted Stock Units Performance RSUs — We have granted RSUs that have both service and performance conditions to our executives and employees ("Performance RSUs"). Vesting of Performance RSUs is subject to continuous service and the satisfaction of certain performance targets. While we recognize cumulative stock-based compensation expense for the portion of the awards for which both the service condition has been satisfied and it is probable that the performance conditions will be met, the actual vesting and settlement of Performance RSUs are subject to the performance conditions actually being met. Market Stock Units In connection with his hiring, in December 2020, the Compensation Committee of our Board of Directors approved the grant of 0.7 million RSUs subject to certain market conditions ("MSUs") to our President and CEO. These MSUs have a weighted average grant date fair value per unit of $ 35.69 and will vest up to 133 % based upon the achievement of certain stock price targets over a performance period of approximately 4.0 years, subject to his continuous service on each vesting date. In October 2021 and August 2022, the Compensation Committee of our Board of Directors approved the grant of approximately 0.4 million and 1.3 million MSUs, respectively, to certain of our executives. These MSUs have a weighted average grant date fair value per unit of approximately $ 46.20 and $ 27.89 , respectively, and will vest up to 200 % of the target number of MSUs based upon our total shareholder return relative to the total shareholder return of companies in the Nasdaq Composite Index over a performance period of approximately 2.8 years and 2.9 years, respectively, subject to continuous service on each vesting date. Additional MSUs have been granted with similar terms, but were not material. We used Monte Carlo simulations to calculate the fair value of these awards on the grant date, or modification date, as applicable. A Monte Carlo simulation requires the use of various assumptions, including the stock price volatility and risk-free interest rate as of the valuation date corresponding to the length of time remaining in the performance period and expected dividend yield. We recognize stock-based compensation expense related to these MSUs using the graded vesting attribution method over the respective performance periods. As of January 31, 2023 , approximately 2.1 million MSUs remained outstanding. Below is a summary of RSU activity, including MSUs, under the Stock Plans: Number of Weighted Average (in thousands) Outstanding at July 31, 2022 22,136 $ 29.81 Granted 15,804 $ 18.43 Released ( 5,287 ) $ 29.63 Forfeited ( 3,134 ) $ 27.70 Outstanding at January 31, 2023 29,519 $ 23.98 Stock Options We did no t grant any stock options during the six months ended January 31, 2023 . A total of 0.4 million stock options were exercised during the six months ended January 31, 2023 , with a weighted average exercise price per share of $ 7.24 . As of January 31, 2023 , 1.3 million stock options, with a weighted average exercise price of $ 6.20 per share, a weighted average remaining contractual life of 1.5 years and an aggregate intrinsic value of $ 28.6 million, remained outstanding. Employee Stock Purchase Plan In December 2015, the Board adopted the 2016 Employee Stock Purchase Plan, which was subsequently amended in January 2016 and September 2016 and approved by our stockholders in March 2016 (the "Original 2016 ESPP"). The Original 2016 ESPP became effective in connection with our IPO. Our stockholders subsequently approved amendments to the Original 2016 ESPP in December 2019 and December 2022 (as amended, the "Amended 2016 ESPP"). Under the Amended 2016 ESPP, the maximum number of shares of Class A common stock available for sale is 13.8 million shares. The 2016 ESPP allows eligible employees to purchase shares of our Class A common stock at a discount through payroll deductions of up to 15 % of eligible compensation, subject to caps of $ 25,000 in any calendar year and 1,000 shares on any purchase date. The 2016 ESPP provides for 12-month offering periods, generally beginning in March and September of each year, and each offering period consists of two six-month purchase periods. On each purchase date, participating employees will purchase Class A common stock at a price per share equal to 85 % of the lesser of the fair market value of our Class A common stock on (i) the first trading day of the applicable offering period or (ii) the last trading day of each purchase period in the applicable offering period. If the stock price of our Class A common stock on any purchase date in an offering period is lower than the stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new offering period. During the six months ended January 31, 2023 , 1.0 million shares of common stock were purchased under the 2016 ESPP for an aggregate amount of $ 18.9 million. As of January 31, 2023 , 13.8 million shares were available for future issuance under the 2016 ESPP. We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant: Six Months Ended January 31, 2022 2023 Expected term (in years) 0.77 0.86 Risk-free interest rate 0.1 % 4.0 % Volatility 53.3 % 64.3 % Dividend yield — % — % Stock-Based Compensation Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Cost of revenue: Product $ 1,948 $ 2,113 $ 3,699 $ 4,272 Support, entitlements and other services 7,806 8,172 16,257 13,518 Sales and marketing 26,380 23,570 55,512 44,042 Research and development 35,763 36,491 74,242 75,113 General and administrative 16,148 14,944 28,882 29,300 Total stock-based compensation expense $ 88,045 $ 85,290 $ 178,592 $ 166,245 As of January 31, 2023 , unrecognized stock-based compensation expense related to outstanding stock awards was approximately $ 653.6 million and is expected to be recognized over a weighted average period of approximately 2.8 years.

Income Taxes

Income Taxes	6 Months Ended
	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 11. IN COME TAXES The income tax provisions of $ 5.3 million and $ 9.4 million for the three and six months ended January 31, 2022 , respectively, and $ 4.2 million and $ 9.6 million for the three and six months ended January 31, 2023, respectively, primarily consisted of foreign taxes on our international operations and U.S. state income taxes. We continue to maintain a full valuation allowance for our U.S. Federal and state deferred tax assets and a partial valuation allowance related to our foreign net deferred tax assets. The Internal Revenue Code Section 174, which requires the mandatory capitalization and amortization of research and development expense, became effective for us for our fiscal 2023. Although Congress has considered legislation that would defer, modify or repeal the capitalization and amortization requirement, there is no assurance that the provision will be deferred, repealed, or otherwise modified. If the requirement is not modified, we may be required to utilize some of our federal and state tax attributes and there may be increases to state cash taxes.

Restructuring Charges

Restructuring Charges	6 Months Ended
	Jan. 31, 2023
Restructuring Charges [Abstract]
Restructuring Charges	NOTE 12. RESTRUCTURING CHARGES In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represents approximately 4 % of our total employees , following a review of our business structure and after taking other cost-cutting measures to reduce expenses. The headcount reduction is part of our ongoing efforts to drive towards profitable growth. As of January 31, 2023 , we recognized total restructuring charges of approximately $ 16.5 million, which consisted primarily of one-time severance and other termination benefit costs directly related to this reduction in force. Of the $ 16.5 million recognized, $ 0.4 million is included within support, entitlements and other services cost of revenue, $ 13.6 million is included within sales and marketing expense, $ 2.3 million is included within research and development expense, and $ 0.2 million is included within general and administrative expense on our condensed consolidated statements of operations. During the fiscal quarter ended January 31, 2023, we made cash payments of $ 4.4 million. As of January 31, 2023 , we had a remaining restructuring liability of $ 0.6 million, included within accrued compensation and benefits in our condensed consolidated balance sheet. We do not expect to record any material future charges related to this reduction in force.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jan. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	NOTE 13. NET L OSS PER SHARE Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by giving effect to potentially dilutive common stock equivalents outstanding during the period, as their effect would be dilutive. Potentially dilutive common shares include participating securities and shares issuable upon the exercise of stock options, the exercise of common stock warrants, the exercise of convertible preferred stock warrants, the vesting of RSUs and each purchase under the 2016 ESPP, under the if-converted method. In loss periods, basic net loss per share and diluted net loss per share are the same, as the effect of potential common shares is antidilutive and therefore excluded. Effective January 3, 2022, all of our then outstanding shares of Class B common stock, par value $ 0.000025 per share, were automatically converted into the same number of shares of the Company’s Class A common stock, par value $ 0.000025 per share, pursuant to the terms of our Amended and Restated Certificate of Incorporation. Prior to this conversion, the rights, including the liquidation and dividend rights, of the holders of our Class A and Class B common stock were identical, except with respect to voting. As the liquidation and dividend rights were identical, our undistributed earnings or losses were allocated on a proportionate basis among the holders of both Class A and Class B common stock. As a result, the net income (loss) per share attributed to common stockholders was the same for both Class A and Class B common stock on an individual or combined basis. The computation of basic and diluted net loss per share attributable to common stockholders is as follows: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands, except per share data) Numerator: Net loss $ ( 115,416 ) $ ( 70,790 ) $ ( 535,622 ) $ ( 170,304 ) Denominator: Weighted average shares—basic and diluted 218,808 231,924 217,153 230,229 Net loss per share attributable to common stockholders— $ ( 0.53 ) $ ( 0.31 ) $ ( 2.47 ) $ ( 0.74 ) The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows: Six Months Ended January 31, 2022 2023 (in thousands) Outstanding stock options and RSUs 27,421 30,841 Employee stock purchase plan 1,683 2,933 Common stock issuable upon the conversion of the Notes 39,968 36,986 Total 69,072 70,760 Shares that will be issued in connection with our stock awards and shares that will be purchased under the employee stock purchase plan are generally automatically converted into shares of our Class A common stock. Common stock issuable upon the conversion of convertible debt represents the antidilutive impact of the 2023 Notes, 2026 Notes and 2027 Notes under the if-converted method.

Segment Information

Segment Information	6 Months Ended
	Jan. 31, 2023
Segment Reporting [Abstract]
Segment Information	NOTE 14. SEGME NT INFORMATION Our chief operating decision maker is a group which is comprised of our Chief Executive Officer and Chief Financial Officer. This group reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment. The following table sets forth revenue by geographic location based on bill-to location: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) U.S. $ 226,437 $ 275,407 $ 443,587 $ 531,137 Europe, the Middle East and Africa 97,584 121,564 181,579 221,817 Asia Pacific 74,844 79,202 140,527 148,305 Other Americas 14,216 10,322 25,905 18,845 Total revenue $ 413,081 $ 486,495 $ 791,598 $ 920,104 The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location: As of July 31, January 31, (in thousands) United States $ 74,472 $ 76,350 International 38,968 36,234 Total long-lived assets $ 113,440 $ 112,584

Overview and Basis of Present_2

Overview and Basis of Presentation (Policies)	6 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation and Significant Accounting Policies	Principles of Consolidation and Significant Accounting Policies The accompanying condensed consolidated financial statements, which include the accounts of Nutanix, Inc. and its wholly-owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States ("U.S. GAAP") and are consistent in all material respects with those included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022, filed with the Securities and Exchange Commission ("SEC") on September 21, 2022. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements are unaudited, but include all adjustments of a normal recurring nature necessary for a fair presentation of our quarterly results. The consolidated balance sheet as of July 31, 2022 is derived from audited financial statements; however, it does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in our Annual Report on Form 10-K for the fiscal year ended July 31, 2022 .
Use of Estimates	Use of Estimates The preparation of interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates and assumptions include, but are not limited to, the best estimate of selling prices for products and related support; useful lives and recoverability of intangible assets and property and equipment; allowance for credit losses; determination of fair value of stock-based awards; accounting for income taxes, including the valuation allowance on deferred tax assets and uncertain tax positions; warranty liability; purchase commitment liabilities to our contract manufacturers; sales commissions expense and the period of benefit for deferred commissions; whether an arrangement is or contains a lease; the incremental borrowing rate to measure the present value of right-of-use assets and lease liabilities; the inputs used to determine the fair value of the contingent liability associated with the conversion feature of the 2.50 % convertible senior notes due 2026 (the "2026 Notes"); and contingencies and litigation. Management evaluates these estimates and assumptions on an ongoing basis using historical experience and other factors and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Concentration Risk	Concentration of Risk Concentration of revenue and accounts receivable —We sell our products primarily through our Partners and occasionally directly to end customers. For the three and six months ended January 31, 2022 and 2023 , no end customer accounted for more than 10 % of total revenue or accounts receivable, except for one end customer that accounted for 24 % of the accounts receivable balance as of January 31, 2023. For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Three Months Ended Six Months Ended July 31, January 31, Partners 2022 2023 2022 2023 Partner A 14 % 12 % 14 % 15 % 11 % 16 % Partner B 34 % 33 % 33 % 32 % 26 % 12 % Partner C (1) (1) (1) (1) (1) 10 % Partner D (1) 10 % 11 % 11 % (1) (1) (1) Less than 10%

REVISION TO PRIOR PERIOD FINA_2

REVISION TO PRIOR PERIOD FINANCIAL STATEMENT (Tables)	6 Months Ended
	Jan. 31, 2023
Prior Period Adjustment [Abstract]
Schedule Of Condensed Financial Statements	As of July 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Balance Sheet: Accrued expenses and other current liabilities $ 49,232 $ 10,336 $ 59,568 Total current liabilities $ 1,150,224 $ 10,336 $ 1,160,560 Total liabilities $ 3,155,917 $ 10,336 $ 3,166,253 Accumulated deficit $ ( 4,368,026 ) $ ( 10,336 ) $ ( 4,378,362 ) Total stockholders’ deficit $ ( 790,168 ) $ ( 10,336 ) $ ( 800,504 )
Schedule of Condensed Consolidated Statement of Operations	Three Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Operations: Sales and marketing $ 241,633 $ 93 $ 241,726 Research and development $ 141,608 $ 262 $ 141,870 Total operating expenses $ 427,532 $ 355 $ 427,887 Loss from operations $ ( 94,420 ) $ ( 355 ) $ ( 94,775 ) Loss before provision for income taxes $ ( 109,752 ) $ ( 355 ) $ ( 110,107 ) Net loss $ ( 115,061 ) $ ( 355 ) $ ( 115,416 ) Net loss per share attributable to Class A and Class $ ( 0.53 ) $ ( 0.00 ) $ ( 0.53 ) Six Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Operations: Sales and marketing $ 491,666 $ 186 $ 491,852 Research and development $ 285,874 $ 523 $ 286,397 Total operating expenses $ 861,859 $ 709 $ 862,568 Loss from operations $ ( 231,676 ) $ ( 709 ) $ ( 232,385 ) Loss before provision for income taxes $ ( 525,557 ) $ ( 709 ) $ ( 526,266 ) Net loss $ ( 534,913 ) $ ( 709 ) $ ( 535,622 ) Net loss per share attributable to Class A and Class $ ( 2.46 ) $ ( 0.01 ) $ ( 2.47 ) Three Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Comprehensive Loss: Net loss $ ( 115,061 ) $ ( 355 ) $ ( 115,416 ) Comprehensive loss $ ( 116,837 ) $ ( 355 ) $ ( 117,192 ) Six Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Comprehensive Loss: Net loss $ ( 534,913 ) $ ( 709 ) $ ( 535,622 ) Comprehensive loss $ ( 537,340 ) $ ( 709 ) $ ( 538,049 )
Schedule of Condensed Consolidated Statement of Comprehensive Loss
Schedule Of Condensed Consolidated Statement of Cash Flows	As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Stockholders' Deficit: Accumulated Deficit as of: July 31, 2021 $ ( 3,627,355 ) $ ( 8,928 ) $ ( 3,636,283 ) October 31, 2021 $ ( 3,990,340 ) $ ( 9,282 ) $ ( 3,999,622 ) January 31, 2022 $ ( 4,105,401 ) $ ( 9,637 ) $ ( 4,115,038 ) July 31, 2022 $ ( 4,368,026 ) $ ( 10,336 ) $ ( 4,378,362 ) October 31, 2022 $ ( 4,467,142 ) $ ( 10,734 ) $ ( 4,477,876 ) Total Stockholders' Deficit as of: July 31, 2021 $ ( 1,012,041 ) $ ( 8,928 ) $ ( 1,020,969 ) October 31, 2021 $ ( 698,739 ) $ ( 9,282 ) $ ( 708,021 ) January 31, 2022 $ ( 725,617 ) $ ( 9,637 ) $ ( 735,254 ) July 31, 2022 $ ( 790,168 ) $ ( 10,336 ) $ ( 800,504 ) October 31, 2022 $ ( 791,049 ) $ ( 10,734 ) $ ( 801,783 ) Net Loss for the Three Months Ended: October 31, 2021 $ ( 419,852 ) $ ( 354 ) $ ( 420,206 ) January 31, 2022 $ ( 115,061 ) $ ( 355 ) $ ( 115,416 ) October 31, 2022 $ ( 99,116 ) $ ( 398 ) $ ( 99,514 )
Schedule Of Condensed Consolidated Stockholder's Deficit	Six Months Ended January 31, 2022 As Previously Reported Adjustments As Corrected (in thousands) Condensed Consolidated Statement of Cash Flows: Net loss $ ( 534,913 ) $ ( 709 ) $ ( 535,622 ) Accrued expenses and other liabilities $ ( 3,371 ) $ 709 $ ( 2,662 )

Overview and Basis of Present_3

Overview and Basis of Presentation (Tables)	6 Months Ended
	Jan. 31, 2023
Accounting Policies [Abstract]
Schedules of Concentration of Revenue and Accounts Receivable	For each significant Partner, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable as of Three Months Ended Six Months Ended July 31, January 31, Partners 2022 2023 2022 2023 Partner A 14 % 12 % 14 % 15 % 11 % 16 % Partner B 34 % 33 % 33 % 32 % 26 % 12 % Partner C (1) (1) (1) (1) (1) 10 % Partner D (1) 10 % 11 % 11 % (1) (1) (1) Less than 10%

Revenue, Deferred Revenue and_2

Revenue, Deferred Revenue and Deferred Commissions (Tables)	6 Months Ended
	Jan. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]
Revenue by Arrangement, Disclosure	The following table depicts the disaggregation of revenue by revenue type, consistent with how we evaluate our financial performance: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Subscription $ 374,744 $ 450,948 $ 712,645 $ 853,872 Non-portable software 14,542 10,875 28,879 18,658 Hardware 1,753 1,230 3,916 1,854 Professional services 22,042 23,442 46,158 45,720 Total revenue $ 413,081 $ 486,495 $ 791,598 $ 920,104
Deferred Revenue, by Arrangement, Disclosure	Significant changes in the balance of deferred revenue (contract liability) and deferred commissions (contract asset) for the periods presented are as follows: Deferred Deferred (in thousands) Balance as of July 31, 2022 $ 1,445,538 $ 367,590 Additions (1) 469,647 33,112 Revenue/commissions recognized ( 433,609 ) ( 48,325 ) Balance as of October 31, 2022 1,481,576 352,377 Additions (1) 531,230 46,439 Revenue/commissions recognized ( 486,495 ) ( 50,336 ) Balance as of January 31, 2023 $ 1,526,311 $ 348,480 (1) Includes both billed and unbilled amounts.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jan. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities Measured on Recurring Basis	The fair value of our financial assets measured on a recurring basis is as follows: As of July 31, 2022 Level I Level II Level III Total (in thousands) Financial Assets: Cash equivalents: Money market funds $ 227,796 $ — $ — $ 227,796 Commercial paper — 27,927 — 27,927 Short-term investments: Corporate bonds — 409,024 — 409,024 Commercial paper — 317,738 — 317,738 U.S. Government securities — 194,667 — 194,667 Total measured at fair value $ 227,796 $ 949,356 $ — $ 1,177,152 Cash 147,127 Total cash, cash equivalents and short-term investments $ 1,324,279 As of January 31, 2023 Level I Level II Level III Total (in thousands) Financial Assets: Cash equivalents: Money market funds $ 236,317 $ — $ — $ 236,317 U.S. Government securities — 2,979 — 2,979 Commercial paper — 27,928 — 27,928 Short-term investments: Corporate bonds — 467,686 — 467,686 Commercial paper — 235,575 — 235,575 U.S. Government securities — 201,502 — 201,502 Total measured at fair value $ 236,317 $ 935,670 $ — $ 1,171,987 Cash 139,377 Total cash, cash equivalents and short-term investments $ 1,311,364 The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: As of July 31, 2022 As of January 31, 2023 Carrying Estimated Carrying Estimated (in thousands) 2023 Notes $ 145,456 $ 143,154 $ — $ — 2026 Notes 589,200 759,086 618,995 973,154 2027 Notes 567,005 400,252 567,769 501,095 Total $ 1,301,661 $ 1,302,492 $ 1,186,764 $ 1,474,249

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date	The following table summarizes the estimated fair value of our investments in marketable debt securities by their contractual maturity dates: As of (in thousands) Due within one year $ 675,573 Due in one to two years 229,190 Total $ 904,763
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consists of the following: As of July 31, January 31, (in thousands) Prepaid operating expenses $ 48,842 $ 52,495 VAT receivables 7,514 5,919 Other current assets 37,431 57,349 Total prepaid expenses and other current assets $ 93,787 $ 115,763
Schedule of Property and Equipment, Net	Property and equipment, net consists of the following: As of Estimated July 31, January 31, (in months) (in thousands) Computer, production, engineering and other equipment 36 $ 341,536 $ 365,480 Demonstration units 12 61,914 62,474 Leasehold improvements (1) 61,443 63,174 Furniture and fixtures 60 16,508 16,237 Total property and equipment, gross 481,401 507,365 Less: accumulated depreciation ( 367,961 ) ( 394,781 ) Total property and equipment, net $ 113,440 $ 112,584 (1) Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.
Schedule of Intangible Assets, Net	There was no change in the carrying value of goodwill during the six months ended January 31, 2023. Intangible assets, net consists of the following: As of July 31, January 31, (in thousands) Developed technology $ 79,300 $ 79,300 Customer relationships 8,860 8,860 Trade name 4,170 4,170 Total intangible assets, gross 92,330 92,330 Less: Accumulated amortization of developed technology ( 64,344 ) ( 69,684 ) Accumulated amortization of customer relationships ( 8,074 ) ( 8,535 ) Accumulated amortization of trade name ( 4,083 ) ( 4,170 ) Total accumulated amortization ( 76,501 ) ( 82,389 ) Total intangible assets, net $ 15,829 $ 9,941
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The estimated future amortization expense of our intangible assets is as follows: Fiscal Year Ending July 31: Amount (in thousands) 2023 (remaining six months) $ 4,968 2024 3,210 2025 1,763 Total $ 9,941
Schedule of Accrued Liabilities	Accrued Compensation and Benefits Accrued compensation and benefits consists of the following: As of July 31, January 31, (in thousands) Contributions to ESPP withheld $ 19,174 $ 26,067 Accrued commissions 32,886 24,400 Accrued vacation 23,140 23,144 Payroll taxes payable 21,060 16,751 Accrued wages and taxes 20,807 13,809 Accrued benefits 11,774 12,914 Accrued bonus 9,782 11,175 Other 11,188 10,083 Total accrued compensation and benefits $ 149,811 $ 138,343 Accrued expenses and other current liabilities consists of the following: As of July 31, January 31, (in thousands) Litigation settlement reserves $ 9,750 $ 71,000 Software usage liability 10,336 11,133 Income taxes payable 13,206 5,613 Accrued professional services 5,499 901 Other 20,777 19,611 Total accrued expenses and other current liabilities $ 59,568 $ 108,258

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	6 Months Ended
	Jan. 31, 2023
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2023 Notes consisted of the following: As of July 31, January 31, (in thousands) Principal amounts: Principal $ 145,704 $ 145,704 Unamortized debt issuance costs (1) ( 248 ) — Repayment of convertible senior notes — ( 145,704 ) Net carrying amount $ 145,456 $ — (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. The effective interest rate was 0.41 %.
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2023 Notes: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Interest expense related to amortization of debt $ 148 $ 99 $ 548 $ 248
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2026 Notes consisted of the following: As of July 31, January 31, (in thousands) Principal amounts: Principal $ 750,000 $ 750,000 Non-cash interest expense converted to principal 27,997 37,722 Unamortized debt discount (conversion feature) (1) ( 169,438 ) ( 151,426 ) Unamortized debt issuance costs (1) ( 19,359 ) ( 17,301 ) Net carrying amount $ 589,200 $ 618,995 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %.
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2026 Notes: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Interest expense related to amortization of debt $ 8,469 $ 9,085 $ 16,789 $ 18,012 Interest expense related to amortization of debt 968 1,038 1,919 2,058 Non-cash interest expense 4,802 4,923 9,575 9,817 Total interest expense $ 14,239 $ 15,046 $ 28,283 $ 29,887
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Components of Notes	The 2027 Notes consisted of the following: As of July 31, January 31, (in thousands) Principal amounts: Principal $ 575,000 $ 575,000 Unamortized debt issuance costs (1) ( 7,995 ) ( 7,231 ) Net carrying amount $ 567,005 $ 567,769 (1) Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.
Interest Expense Recognized	The following table sets forth the total interest expense recognized related to the 2027 Notes: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Contractual interest expense $ 359 $ 359 $ 511 $ 718 Interest expense related to amortization of debt 380 382 540 764 Total interest expense $ 739 $ 741 $ 1,051 $ 1,482

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jan. 31, 2023
Leases [Abstract]
Assets and Liabilities, Lessee	Supplemental balance sheet information related to leases is as follows: As of July 31, January 31, (in thousands) Operating leases: Operating lease right-of-use assets, gross $ 188,060 $ 191,509 Accumulated amortization ( 69,320 ) ( 84,798 ) Operating lease right-of-use assets, net $ 118,740 $ 106,711 Operating lease liabilities—current $ 39,801 $ 34,101 Operating lease liabilities—non-current 89,782 80,585 Total operating lease liabilities $ 129,583 $ 114,686 Weighted average remaining lease term (in years): 5.1 5.0 Weighted average discount rate: 5.7 % 5.8 % As of July 31, January 31, (in thousands) Finance leases: Finance lease right-of-use assets, gross (1) $ 13,501 $ 12,879 Accumulated amortization (1) ( 3,053 ) ( 3,793 ) Finance lease right-of-use assets , net (1) $ 10,448 $ 9,086 Finance lease liabilities—current (2) $ 2,685 $ 2,525 Finance lease liabilities—non-current (3) 7,806 7,042 Total finance lease liabilities $ 10,491 $ 9,567 Weighted average remaining lease term (in years): 3.9 3.6 Weighted average discount rate: 5.9 % 6.2 % (1) Included in the condensed consolidated balance sheets within property and equipment, net. (2) Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. (3) Included in the condensed consolidated balance sheets within other liabilities—non-current.
Supplemental Cash Flow and Other Information Related to Leases	Supplemental cash flow and other information related to leases is as follows: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Cash paid for amounts included in the measurement of Operating cash flows from operating leases $ 12,081 $ 11,914 $ 25,557 $ 23,763 Financing cash flows from finance leases $ 104 $ 488 $ 323 $ 2,344 Lease liabilities arising from obtaining right-of-use assets: Operating leases $ — $ 4,625 $ 3,950 $ 5,971 Finance leases $ 3,873 $ 1,543 $ 3,873 $ 1,543
Lessee Operating and Finance Lease, Liability, Maturity	The undiscounted cash flows for our operating lease liabilities as of January 31, 2023 were as follows: Fiscal Year Ending July 31: Operating Finance Total (in thousands) 2023 $ 19,718 $ 1,447 $ 21,165 2024 31,266 3,059 34,325 2025 18,341 3,059 21,400 2026 14,698 2,357 17,055 2027 13,463 647 14,110 Thereafter 38,720 116 38,836 Total lease payments 136,206 10,685 146,891 Less: imputed interest ( 21,520 ) ( 1,118 ) ( 22,638 ) Total lease obligation 114,686 9,567 124,253 Less: current lease obligations ( 34,101 ) ( 2,525 ) ( 36,626 ) Long-term lease obligations $ 80,585 $ 7,042 $ 87,627

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	6 Months Ended
	Jan. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of RSUs Activity	Below is a summary of RSU activity, including MSUs, under the Stock Plans: Number of Weighted Average (in thousands) Outstanding at July 31, 2022 22,136 $ 29.81 Granted 15,804 $ 18.43 Released ( 5,287 ) $ 29.63 Forfeited ( 3,134 ) $ 27.70 Outstanding at January 31, 2023 29,519 $ 23.98
Schedule of ESPP Valuation Assumptions	We use the Black-Scholes option pricing model to determine the fair value of shares purchased under the 2016 ESPP with the following weighted average assumptions on the date of grant: Six Months Ended January 31, 2022 2023 Expected term (in years) 0.77 0.86 Risk-free interest rate 0.1 % 4.0 % Volatility 53.3 % 64.3 % Dividend yield — % — %
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) Cost of revenue: Product $ 1,948 $ 2,113 $ 3,699 $ 4,272 Support, entitlements and other services 7,806 8,172 16,257 13,518 Sales and marketing 26,380 23,570 55,512 44,042 Research and development 35,763 36,491 74,242 75,113 General and administrative 16,148 14,944 28,882 29,300 Total stock-based compensation expense $ 88,045 $ 85,290 $ 178,592 $ 166,245

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jan. 31, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The computation of basic and diluted net loss per share attributable to common stockholders is as follows: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands, except per share data) Numerator: Net loss $ ( 115,416 ) $ ( 70,790 ) $ ( 535,622 ) $ ( 170,304 ) Denominator: Weighted average shares—basic and diluted 218,808 231,924 217,153 230,229 Net loss per share attributable to common stockholders— $ ( 0.53 ) $ ( 0.31 ) $ ( 2.47 ) $ ( 0.74 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows: Six Months Ended January 31, 2022 2023 (in thousands) Outstanding stock options and RSUs 27,421 30,841 Employee stock purchase plan 1,683 2,933 Common stock issuable upon the conversion of the Notes 39,968 36,986 Total 69,072 70,760

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Jan. 31, 2023
Segment Reporting [Abstract]
Schedule of Revenue by Geographic Area	The following table sets forth revenue by geographic location based on bill-to location: Three Months Ended Six Months Ended 2022 2023 2022 2023 (in thousands) U.S. $ 226,437 $ 275,407 $ 443,587 $ 531,137 Europe, the Middle East and Africa 97,584 121,564 181,579 221,817 Asia Pacific 74,844 79,202 140,527 148,305 Other Americas 14,216 10,322 25,905 18,845 Total revenue $ 413,081 $ 486,495 $ 791,598 $ 920,104
Schedule of Long-lived Assets by Geographical Location	The following table sets forth long-lived assets, which primarily include property and equipment, net, by geographic location: As of July 31, January 31, (in thousands) United States $ 74,472 $ 76,350 International 38,968 36,234 Total long-lived assets $ 113,440 $ 112,584

Overview and Basis of Present_4

Overview and Basis of Presentation - Schedules of Concentration of Revenue and Accounts Receivable (Details) - Partner Concentration Risk		3 Months Ended		6 Months Ended		12 Months Ended
		Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022
Partner A | Revenue
Concentration Risk [Line Items]
Concentration risk percentage		12%	14%	14%	15%
Partner A | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage				16%		11%
Partner B | Revenue
Concentration Risk [Line Items]
Concentration risk percentage		33%	34%	33%	32%
Partner B | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage				12%		26%
Partner D | Revenue
Concentration Risk [Line Items]
Concentration risk percentage		10%		11%	11%
Partner D | Accounts Receivable
Concentration Risk [Line Items]
Concentration risk percentage	[1]			10%
[1] Less than 10%

Overview and Basis of Present_5

Overview and Basis of Presentation - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022	Aug. 01, 2021	Sep. 30, 2020	Sep. 24, 2020	Jan. 31, 2018
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, immaterial effect						false
Accumulated deficit	$ (4,548,666)		$ (4,548,666)		$ (4,378,362)
Partner [Member] | Customer Concentration Risk [Member] | Revenue
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Concentration risk percentage	10%	10%	10%	10%
Partner [Member] | Customer Concentration Risk [Member] | Accounts Receivable
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Concentration risk percentage			24%
2026 Convertible Senior Notes | Convertible Debt [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Principal value							$ 750,000
Interest rate, stated percentage	2.50%		2.50%					2.50%
2023 Convertible Senior Notes | Convertible Debt [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Principal value									$ 575,000
Interest rate, stated percentage									0%
ASU 2020-06
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted						false
Change in accounting principle, accounting standards update, immaterial effect						false
Accounting Standards Update 2021-04 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Change in accounting principle, accounting standards update, adopted						false

CORRECTION TO PRIOR PERIOD FINA

CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENT - Summery Of impact of this revision on our condensed consolidated balance sheet (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021
Condensed Consolidated Balance Sheet:
Accrued expenses and other current liabilities	$ 108,258		$ 59,568
Total current liabilities	1,112,267		1,160,560
Total liabilities	3,154,177		3,166,253
Accumulated deficit	(4,548,666)		(4,378,362)
Total stockholders’ deficit	$ (782,682)	$ (801,783)	(800,504)	$ (735,254)	$ (708,021)	$ (1,020,969)
As Previously Reported [Member]
Condensed Consolidated Balance Sheet:
Accrued expenses and other current liabilities			49,232
Total current liabilities			1,150,224
Total liabilities			3,155,917
Accumulated deficit		(4,467,142)	(4,368,026)	(4,105,401)	(3,990,340)	(3,627,355)
Total stockholders’ deficit		(791,049)	(790,168)	(725,617)	(698,739)	(1,012,041)
Adjustment [Member]
Condensed Consolidated Balance Sheet:
Accrued expenses and other current liabilities			10,336
Total current liabilities			10,336
Total liabilities			10,336
Accumulated deficit		(10,734)	(10,336)	(9,637)	(9,282)	(8,928)
Total stockholders’ deficit		(10,734)	(10,336)	(9,637)	(9,282)	(8,928)
As Corrected [Member]
Condensed Consolidated Balance Sheet:
Accrued expenses and other current liabilities			59,568
Total current liabilities			1,160,560
Total liabilities			3,166,253
Accumulated deficit		(4,477,876)	(4,378,362)	(4,115,038)	(3,999,622)	(3,636,283)
Total stockholders’ deficit		$ (801,783)	$ (800,504)	$ (735,254)	$ (708,021)	$ (1,020,969)

CORRECTION TO PRIOR PERIOD FI_2

CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENT - Summery Of Condensed Consolidated Statement of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended				6 Months Ended
		Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2023	Jan. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales and marketing		$ 229,788		$ 241,726		$ 466,010	$ 491,852
Research and development		142,301		141,870		291,744	286,397
Total operating expenses		456,198		427,887		887,967	862,568
Loss from operations		(56,508)		(94,775)		(137,163)	(232,385)
Loss before provision for income taxes		(66,620)		(110,107)		(160,691)	(526,266)
Net loss		$ (70,790)	$ (99,514)	$ (115,416)	$ (420,206)	$ (170,304)	$ (535,622)
Net loss per share attributable to Class A common stockholders-basic	[1]	$ (0.31)		$ (0.53)		$ (0.74)	$ (2.47)
Net loss per share attributable to Class A common stockholders-diluted	[1]	$ (0.31)		$ (0.53)		$ (0.74)	$ (2.47)
As Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales and marketing				$ 241,633			$ 491,666
Research and development				141,608			285,874
Total operating expenses				427,532			861,859
Loss from operations				(94,420)			(231,676)
Loss before provision for income taxes				(109,752)			(525,557)
Net loss			(99,116)	$ (115,061)	(419,852)		$ (534,913)
Net loss per share attributable to Class A common stockholders-basic				$ (0.53)			$ (2.46)
Net loss per share attributable to Class A common stockholders-diluted				$ (0.53)			$ (2.46)
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales and marketing				$ 93			$ 186
Research and development				262			523
Total operating expenses				355			709
Loss from operations				(355)			(709)
Loss before provision for income taxes				(355)			(709)
Net loss			(398)	$ (355)	(354)		$ (709)
Net loss per share attributable to Class A common stockholders-basic				$ 0			$ (0.01)
Net loss per share attributable to Class A common stockholders-diluted				$ 0			$ (0.01)
As Corrected [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales and marketing				$ 241,726			$ 491,852
Research and development				141,870			286,397
Total operating expenses				427,887			862,568
Loss from operations				(94,775)			(232,385)
Loss before provision for income taxes				(110,107)			(526,266)
Net loss			$ (99,514)	$ (115,416)	$ (420,206)		$ (535,622)
Net loss per share attributable to Class A common stockholders-basic				$ (0.53)			$ (2.47)
Net loss per share attributable to Class A common stockholders-diluted				$ (0.53)			$ (2.47)
[1] Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 9 for further details.

CORRECTION TO PRIOR PERIOD FI_3

CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENT - Summery Of Condensed Consolidated Statement of Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2023	Jan. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	$ (70,790)	$ (99,514)	$ (115,416)	$ (420,206)	$ (170,304)	$ (535,622)
Comprehensive loss	$ (66,873)		(117,192)		$ (170,029)	(538,049)
As Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		(99,116)	(115,061)	(419,852)		(534,913)
Comprehensive loss			(116,837)			(537,340)
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		(398)	(355)	(354)		(709)
Comprehensive loss			(355)			(709)
As Corrected [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		$ (99,514)	(115,416)	$ (420,206)		(535,622)
Comprehensive loss			$ (117,192)			$ (538,049)

CORRECTION TO PRIOR PERIOD FI_4

CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENT - Summery Of Condensed Consolidated Statement of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2023	Jan. 31, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss	$ (70,790)	$ (99,514)	$ (115,416)	$ (420,206)	$ (170,304)	$ (535,622)
Accrued expenses and other liabilities					$ 52,423	(2,662)
As Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		(99,116)	(115,061)	(419,852)		(534,913)
Accrued expenses and other liabilities						(3,371)
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		(398)	(355)	(354)		(709)
Accrued expenses and other liabilities						709
As Corrected [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		$ (99,514)	$ (115,416)	$ (420,206)		(535,622)
Accrued expenses and other liabilities						$ (2,662)

CORRECTION TO PRIOR PERIOD FI_5

CORRECTION TO PRIOR PERIOD FINANCIAL STATEMENT - Summery Condensed Consolidated Stockholder's Deficit (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022	Jul. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accumulated Deficit	$ (4,548,666)				$ (4,548,666)		$ (4,378,362)
Total stockholders’ deficit	(782,682)	$ (801,783)	$ (735,254)	$ (708,021)	(782,682)	$ (735,254)	(800,504)	$ (1,020,969)
Net loss	$ (70,790)	(99,514)	(115,416)	(420,206)	$ (170,304)	(535,622)
As Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accumulated Deficit		(4,467,142)	(4,105,401)	(3,990,340)		(4,105,401)	(4,368,026)	(3,627,355)
Total stockholders’ deficit		(791,049)	(725,617)	(698,739)		(725,617)	(790,168)	(1,012,041)
Net loss		(99,116)	(115,061)	(419,852)		(534,913)
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accumulated Deficit		(10,734)	(9,637)	(9,282)		(9,637)	(10,336)	(8,928)
Total stockholders’ deficit		(10,734)	(9,637)	(9,282)		(9,637)	(10,336)	(8,928)
Net loss		(398)	(355)	(354)		(709)
As Corrected [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Accumulated Deficit		(4,477,876)	(4,115,038)	(3,999,622)		(4,115,038)	(4,378,362)	(3,636,283)
Total stockholders’ deficit		(801,783)	(735,254)	(708,021)		(735,254)	$ (800,504)	$ (1,020,969)
Net loss		$ (99,514)	$ (115,416)	$ (420,206)		$ (535,622)

Revenue, Deferred Revenue and_3

Revenue, Deferred Revenue and Deferred Commissions - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 486,495	$ 413,081	$ 920,104	$ 791,598
Amount deferred in prior period	219,900	186,900	399,300	342,800
Contracted revenue not recognized	$ 1,600,000		$ 1,600,000
Percent expected to be recognized in next year	53%		53%
Ratable
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 224,200	191,300	$ 437,600	374,500
Upfront
Deferred Revenue Arrangement [Line Items]
Total revenue	$ 226,700	$ 183,400	$ 416,300	$ 338,100
Minimum
Deferred Revenue Arrangement [Line Items]
Software, license term			1 year
Maximum
Deferred Revenue Arrangement [Line Items]
Software, license term			5 years

Revenue, Deferred Revenue and_4

Revenue, Deferred Revenue and Deferred Commissions - Revenue by Arrangement, Disclosure (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Condensed Income Statements, Captions [Line Items]
Total revenue	$ 486,495	$ 413,081	$ 920,104	$ 791,598
Subscription
Condensed Income Statements, Captions [Line Items]
Total revenue	450,948	374,744	853,872	712,645
Non-portable software
Condensed Income Statements, Captions [Line Items]
Total revenue	10,875	14,542	18,658	28,879
Hardware
Condensed Income Statements, Captions [Line Items]
Total revenue	1,230	1,753	1,854	3,916
Professional services
Condensed Income Statements, Captions [Line Items]
Total revenue	$ 23,442	$ 22,042	$ 45,720	$ 46,158

Revenue, Deferred Revenue and_5

Revenue, Deferred Revenue and Deferred Commissions - Deferred Revenue, by Arrangement, Disclosure (Details) - USD ($) $ in Thousands		3 Months Ended
		Jan. 31, 2023	Oct. 31, 2022
Movement in Deferred Commissions [Roll Forward]
Deferred commissions, beginning balance		$ 352,377	$ 367,590
Additions	[1]	46,439	33,112
Revenue/commissions recognized		(50,336)	(48,325)
Deferred commissions, ending balance		348,480	352,377
Deferred revenue, beginning balance		1,481,576	1,445,538
Additions	[1]	531,230	469,647
Revenue/commissions recognized		(486,495)	(433,609)
Deferred revenue, ending balance		$ 1,526,311	$ 1,481,576
[1] Includes both billed and unbilled amounts.

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Financial Assets:
Short-term investments:	$ 904,763	$ 921,429
Recurring
Financial Assets:
Total measured at fair value	1,171,987	1,177,152
Cash	139,377	147,127
Total cash, cash equivalents and short-term investments	1,311,364	1,324,279
Recurring | Corporate bonds
Financial Assets:
Short-term investments:	467,686	409,024
Recurring | Money market funds
Financial Assets:
Cash equivalents:	236,317	227,796
Recurring | Commercial paper
Financial Assets:
Cash equivalents:	27,928	27,927
Short-term investments:	235,575	317,738
Recurring | U.S. government securities
Financial Assets:
Cash equivalents:	2,979
Short-term investments:	201,502	194,667
Recurring | Level I
Financial Assets:
Total measured at fair value	236,317	227,796
Recurring | Level I | Corporate bonds
Financial Assets:
Short-term investments:		0
Recurring | Level I | Money market funds
Financial Assets:
Cash equivalents:	236,317	227,796
Recurring | Level I | Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:		0
Recurring | Level I | U.S. government securities
Financial Assets:
Short-term investments:		0
Recurring | Level II
Financial Assets:
Total measured at fair value	935,670	949,356
Recurring | Level II | Corporate bonds
Financial Assets:
Cash equivalents:	467,686
Short-term investments:		409,024
Recurring | Level II | Money market funds
Financial Assets:
Cash equivalents:	0	0
Recurring | Level II | Commercial paper
Financial Assets:
Cash equivalents:	27,928	27,927
Short-term investments:	235,575	317,738
Recurring | Level II | U.S. government securities
Financial Assets:
Cash equivalents:	2,979
Short-term investments:	201,502	194,667
Recurring | Level III
Financial Assets:
Total measured at fair value	0	0
Recurring | Level III | Corporate bonds
Financial Assets:
Cash equivalents:	0
Short-term investments:		0
Recurring | Level III | Money market funds
Financial Assets:
Cash equivalents:	0	0
Recurring | Level III | Commercial paper
Financial Assets:
Cash equivalents:	0	0
Short-term investments:	0	0
Recurring | Level III | U.S. government securities
Financial Assets:
Cash equivalents:	0
Short-term investments:	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
		Jan. 31, 2023	Jul. 31, 2022	Sep. 30, 2021	Sep. 22, 2021	Sep. 15, 2021	Sep. 24, 2020	Jan. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Subject to Master Netting Arrangement, before Offset						$ 698,200
2023 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage								0%
Unamortized debt issuance cost	[1]	$ 0	$ 248
Closing trading price		$ 100
Debt outstanding					$ 145,700
Repayments of debt		$ 145,700
2026 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage		2.50%					2.50%
Non Cash Interest Expense Converted To Principal		$ 37,722	27,997
Unamortized discount	[2]	151,426	169,438
Unamortized debt issuance cost	[2]	$ 17,301	19,359
2027 Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage				0.25%
2027 Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate, stated percentage		0.25%		0.25%
Unamortized debt issuance cost	[3]	$ 7,231	$ 7,995
Closing trading price		$ 100
[1] Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. The effective interest rate was 0.41 %. Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %. Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.

Fair Value Measurements - Non-r

Fair Value Measurements - Non-recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - Convertible Debt - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	$ 1,186,764	$ 1,301,661
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	1,474,249	1,302,492
2023 Convertible Senior Notes | Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	0	145,456
2023 Convertible Senior Notes | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	0	143,154
2026 Convertible Senior Notes | Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	618,995	589,200
2026 Convertible Senior Notes | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	973,154	759,086
2027 Convertible Senior Notes | Reported Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	567,769	567,005
2027 Convertible Senior Notes | Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible senior note, fair value disclosure	$ 501,095	$ 400,252

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Derivative Liability (Details) - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Fair Value Disclosures [Abstract]
Change in fair value	$ 0	$ 198,038

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Investments in Marketable Debt Securities, by Contractual Maturity Date (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]
Due within one year	$ 675,573
Due in one to two years	229,190
Total	$ 904,763	$ 921,429

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid operating expenses	$ 52,495	$ 48,842
VAT receivables	5,919	7,514
Other current assets	57,349	37,431
Total prepaid expenses and other current assets	$ 115,763	$ 93,787

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands		6 Months Ended
		Jan. 31, 2023	Jul. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment, gross		$ 507,365	$ 481,401
Less: accumulated depreciation		(394,781)	(367,961)
Total property and equipment, net		$ 112,584	113,440
Computer, production, engineering and other equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life		36 months
Total property and equipment, gross		$ 365,480	341,536
Demonstration units
Property, Plant and Equipment [Line Items]
Estimated Useful Life		12 months
Total property and equipment, gross		$ 62,474	61,914
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	[1]	$ 63,174	61,443
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated Useful Life		60 months
Total property and equipment, gross		$ 16,237	$ 16,508
[1] Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term.

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Depreciation	$ 15.8	$ 17.7	$ 31.8	$ 36.4

Balance Sheet Components - Sc_4

Balance Sheet Components - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 92,330	$ 92,330
Less:
Total accumulated amortization	(82,389)	(76,501)
Total intangible assets, net	9,941	15,829
Developed technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	79,300	79,300
Less:
Total accumulated amortization	69,684	(64,344)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	8,860	8,860
Less:
Total accumulated amortization	8,535	(8,074)
Trade Names
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	4,170	4,170
Less:
Total accumulated amortization	$ 4,170	$ (4,083)

Balance Sheet Components - Sc_5

Balance Sheet Components - Schedule of Finite-lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Jan. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023 (remaining six months)	$ 4,968
2024	3,210
2025	1,763
Total	$ 9,941

Balance Sheet Components - Sc_6

Balance Sheet Components - Schedule of Accrued Compensation Benefits (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Employee-related Liabilities, Current [Abstract]
Accrued commissions	$ 24,400	$ 32,886
Accrued vacation	23,144	23,140
Payroll taxes payable	16,751	21,060
Accrued Wages and Taxes	13,809	20,807
Contributions to ESPP withheld	26,067	19,174
Accrued benefits	12,914	11,774
Accrued bonus	11,175	9,782
Other	10,083	11,188
Total accrued compensation and benefits	$ 138,343	$ 149,811

Balance Sheet Components - Sc_7

Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Other Liabilities Disclosure [Abstract]
Litigation settlement reserves	$ 71,000	$ 9,750
Software usage liability	11,133	10,336
Income taxes payable	5,613	13,206
Accrued professional services	901	5,499
Other	19,611	20,777
Accrued expenses and other current liabilities	$ 108,258	$ 59,568

Convertible Senior Notes - Addi

Convertible Senior Notes - Additional Information (Details)			1 Months Ended	6 Months Ended
	Sep. 30, 2020 USD ($)	Sep. 24, 2020 USD ($) d $ / shares	Sep. 30, 2021 USD ($) d $ / shares shares	Jan. 31, 2023 USD ($)	Jan. 31, 2022 USD ($)	Jul. 31, 2022 USD ($)	Sep. 22, 2021 USD ($)	Jan. 31, 2018 USD ($) $ / shares
Debt Instrument [Line Items]
Payments for unwinding of warrants				$ 0	$ (18,390,000)
Proceeds from unwinding of convertible note hedges				0	39,880,000
Loss on debt extinguishment				0	(64,910,000)
Proceeds from the issuance of convertible notes, net of issuance costs				0	$ 89,128,000
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Loss on debt extinguishment			$ 64,900,000
Number of securities called by warrants or rights (in shares) | shares			11,800,000
Payments for convertible note hedges			$ 143,200,000
Exercise price of warrants (in dollars per share) | $ / shares								$ 73.46
Proceeds from issuance of warrants			$ 88,000,000
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage			0.25%
Principal amount			$ 1,000,000
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage								0%
Face amount								$ 575,000,000
Principal amount				145,704,000		$ 145,704,000
Debt outstanding							$ 145,700,000
Repayments of debt				$ 145,700,000
Convertible debt			416,500,000
Repurchase amount			12,800,000
Proceeds from unwind transactions			21,500,000
Payments for unwinding of warrants			(18,400,000)
Proceeds from unwinding of convertible note hedges			$ 39,900,000
Conversion price (in dollars per share) | $ / shares								$ 48.85
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage		2.50%		2.50%
Face amount	$ 750,000,000
Principal amount				$ 750,000,000		750,000,000
Conversion ratio		0.036036
Conversion price (in dollars per share) | $ / shares		$ 27.75	$ 27.75
Threshold trading days | d		20
Threshold consecutive trading days | d		30
Threshold percentage of stock price trigger		150%
Redemption price, percentage		100%
Debt instrument, term				3 years 7 months 6 days
Proceeds from the issuance of convertible notes, net of issuance costs	723,700,000
Payments of debt issuance costs	$ 26,300,000
Debt instrument, principal amount for conversion into common stock		$ 1,000,000	$ 1,000,000
Derivative liability		$ 230,900,000	698,200,000
Debt Instrument convertible conversion price 1			1,000,000
Convertible Debt | 2026 Convertible Senior Notes | Common Class A [Member]
Debt Instrument [Line Items]
Debt Instrument convertible conversion excess value			$ 1,000,000
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate, stated percentage			0.25%	0.25%
Face amount			$ 575,000,000
Principal amount				$ 575,000,000		$ 575,000,000
Convertible debt			477,300,000
Debt instrument for cash, net			88,400,000
Notes for cash			97,700,000
Repurchase amount			$ 14,700,000
Conversion ratio			17.3192
Conversion price (in dollars per share) | $ / shares			$ 57.74
Threshold trading days | d			20
Threshold consecutive trading days | d			30
Redemption price, percentage			100%
Debt instrument, term				4 years 8 months 12 days
Debt instrument, principal amount for conversion into common stock			$ 1,000,000
Convertible Debt | 2027 Convertible Senior Notes | Minimum
Debt Instrument [Line Items]
Threshold percentage of stock price trigger			130%
Convertible Debt | 2027 Convertible Senior Notes | Common Class A [Member]
Debt Instrument [Line Items]
Repurchase amount			$ 58,500,000
Number of share repurchase | shares			1,400,000
Convertible Debt | 2027 Convertible Senior Notes | Common Class A [Member] | Maximum
Debt Instrument [Line Items]
Threshold percentage of stock price trigger			98%
Convertible Debt | Exchange Transactions | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Face amount							416,500,000
Convertible Debt | Exchange Transactions | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Face amount							477,300,000
Convertible Debt | Cash Transaction
Debt Instrument [Line Items]
Repayments of debt				$ 145,700,000
Convertible Debt | Cash Transaction | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Repurchase amount							$ 12,800,000

Convertible Senior Notes - Net

Convertible Senior Notes - Net Proceeds from Notes (Details) - 2023 Convertible Senior Notes - USD ($) $ in Thousands	1 Months Ended
	Sep. 30, 2021	Jan. 31, 2023	Jul. 31, 2022
Debt Instrument [Line Items]
Less: cost of the bond hedges	$ (143,200)
Add: proceeds from the sale of warrants	$ 88,000
Convertible Debt
Debt Instrument [Line Items]
Principal amount		$ 145,704	$ 145,704

Convertible Senior Notes - Comp

Convertible Senior Notes - Components of Debt (Details) - USD ($) $ in Thousands		6 Months Ended		12 Months Ended
		Jan. 31, 2023	Jan. 31, 2022	Jul. 31, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Repayment of convertible senior notes		$ 145,704	$ 0
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount					$ 1,000
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount		145,704		$ 145,704
Unamortized debt issuance costs	[1]	0		(248)
Repayment of convertible senior notes		(145,704)		0
Net carrying amount		0		145,456
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount		750,000		750,000
Non-cash interest expense converted to principal		37,722		27,997
Unamortized debt discount	[2]	(151,426)		(169,438)
Unamortized debt issuance costs	[2]	(17,301)		(19,359)
Net carrying amount		618,995		589,200
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Principal amount		575,000		575,000
Unamortized debt issuance costs	[3]	(7,231)		(7,995)
Net carrying amount		$ 567,769		$ 567,005
[1] Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2023 Notes using the effective interest rate method. The effective interest rate was 0.41 %. Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2026 Notes using the effective interest rate method. The effective interest rate is 7.05 %. Included in the condensed consolidated balance sheets within convertible senior notes, net and amortized over the remaining life of the 2027 Notes using the effective interest rate method. The effective interest rate is 0.52 %.

Convertible Senior Notes - Co_2

Convertible Senior Notes - Components of Notes (Parenthetical) (Details) - Convertible Debt	Jan. 31, 2023
2023 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	0.41%
2026 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	7.05%
2027 Convertible Senior Notes
Debt Instrument [Line Items]
Effective interest rate	0.52%

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense Recognized (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Debt Instrument [Line Items]
Non-cash interest expense			$ 9,817	$ 9,575
Convertible Debt | 2023 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt issuance costs	$ 99	$ 148	248	548
Convertible Debt | 2026 Convertible Senior Notes
Debt Instrument [Line Items]
Interest expense related to amortization of debt discount	9,085	8,469	18,012	16,789
Interest expense related to amortization of debt issuance costs	1,038	968	2,058	1,919
Non-cash interest expense	4,923	4,802	9,817	9,575
Total interest expense	15,046	14,239	29,887	28,283
Convertible Debt | 2027 Convertible Senior Notes
Debt Instrument [Line Items]
Contractual interest expense	359	359	718	511
Interest expense related to amortization of debt issuance costs	382	380	764	540
Total interest expense	$ 741	$ 739	$ 1,482	$ 1,051

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease, cost	$ 11.2	$ 10.8	$ 21.9	$ 21.7
Finance lease, cost	1.1	$ 0.6	1.8	$ 1.1
Operating lease expenses	$ 0.8		$ 1.7
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term			1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term			7 years

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet (Details) - USD ($) $ in Thousands		Jan. 31, 2023	Jul. 31, 2022
Operating leases
Operating lease right-of-use assets, gross		$ 191,509	$ 188,060
Accumulated amortization		(84,798)	(69,320)
Operating lease right-of-use assets, net		106,711	118,740
Operating lease liabilities—current		34,101	39,801
Operating lease liabilities—non-current		80,585	89,782
Total lease obligation		$ 114,686	$ 129,583
Weighted average remaining lease term (in years)		5 years	5 years 1 month 6 days
Weighted average discount rate		5.80%	5.70%
Finance leases
Finance lease right-of-use assets, gross	[1]	$ 12,879	$ 13,501
Accumulated amortization	[1]	(3,793)	(3,053)
Finance lease right-of-use assets, net	[1]	9,086	10,448
Finance lease liabilities-current	[2]	2,525	2,685
Finance lease liabilities-non-current	[3]	7,042	7,806
Total lease obligation		$ 9,567	$ 10,491
Weighted average remaining lease term (in years)		3 years 7 months 6 days	3 years 10 months 24 days
Weighted average discount rate		6.20%	5.90%
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]		Other Assets, Noncurrent	Other Assets, Noncurrent
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]		Liabilities, Current	Liabilities, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]		Liabilities	Liabilities
[1] Included in the condensed consolidated balance sheets within property and equipment, net. Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. Included in the condensed consolidated balance sheets within other liabilities—non-current.

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow and Other Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Leases [Abstract]
Operating cash flows from operating leases	$ 11,914	$ 12,081	$ 23,763	$ 25,557
Financing cash flows from finance leases	488	104	2,344	323
Lease liabilities arising from obtaining right-of-use assets from operating leases	4,625	0	5,971	3,950
Lease liabilities arising from obtaining right-of-use assets from finance leases	$ 1,543	$ 3,873	$ 1,543	$ 3,873

Leases - Remaining Maturity Und

Leases - Remaining Maturity Under Topic 842 (Details) - USD ($) $ in Thousands		Jan. 31, 2023	Jul. 31, 2022
Operating Leases
2023		$ 19,718
2024		31,266
2025		18,341
2026		14,698
2027		13,463
Thereafter		38,720
Total lease payments		136,206
Less: imputed interest		(21,520)
Total lease obligation		114,686	$ 129,583
Less: current lease obligations		(34,101)	(39,801)
Long-term lease obligations		80,585	89,782
Finance leases
2023		1,447
2024		3,059
2025		3,059
2026		2,357
2027		647
Thereafter		116
Total lease payments		10,685
Less: imputed interest		(1,118)
Total lease obligation		9,567	10,491
Less: current lease obligations	[1]	(2,525)	(2,685)
Long-term lease obligations	[2]	7,042	$ 7,806
Total
2023		21,165
2024		34,325
2025		21,400
2026		17,055
2027		14,110
Thereafter		38,836
Total lease payments		146,891
Less: imputed interest		(22,638)
Total lease obligation		124,253
Less: current lease obligations		(36,626)
Long-term lease obligations		$ 87,627
[1] Included in the condensed consolidated balance sheets within accrued expenses and other current liabilities. Included in the condensed consolidated balance sheets within other liabilities—non-current.

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) $ in Millions	Jan. 31, 2023 USD ($)
Non-contract Vendors
Loss Contingencies [Line Items]
Purchase obligation	$ 101.3
Contract Manufacturer
Loss Contingencies [Line Items]
Purchase obligation	$ 60.3

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended
	Sep. 30, 2021 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) Vote $ / shares shares	Jan. 31, 2022 USD ($)	Jul. 31, 2022 $ / shares shares	Jan. 03, 2022 Class $ / shares shares
Class of Stock [Line Items]
Number of authorized common stock | Class					1
Common stock, shares authorized (in shares)		1,042,004,000		1,042,004,000
Payments for repurchase of common stock | $		$ 0	$ 58,570
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		1,000,000,000		1,000,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.000025		$ 0.000025	$ 0.000025
Common stock, shares issued (in shares)		233,591,000		226,938,000
Common stock, shares outstanding (in shares)		233,591,000		226,938,000
Common stock number of votes per share | Vote		1
Repurchase and retirement of common stock (in shares)	1,400,000
Stock repurchase price (in dollars per share) | $ / shares	$ 42.77
Payments for repurchase of common stock | $	$ 97,700
Net cash proceeds from the issuance | $	$ 58,500
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized (in shares)				42,004,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.000025		$ 0.000025	$ 0.000025
Common stock, shares issued (in shares)					0

Equity Incentive Plans - Additi

Equity Incentive Plans - Additional Information (Details) $ / shares in Units, $ in Thousands					1 Months Ended				6 Months Ended
	Aug. 01, 2022 shares	Aug. 01, 2021 shares	Dec. 13, 2019 USD ($) PurchasePeriod shares	Dec. 13, 2019 USD ($) PurchasePeriod shares	Aug. 31, 2022 $ / shares shares	Oct. 31, 2021 $ / shares shares	Dec. 31, 2020 $ / shares shares	Sep. 30, 2016 shares	Jan. 31, 2023 USD ($) Plan $ / shares shares	Jan. 31, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | Plan									3
Shares reserved for future issuance (in shares)									44,700,000
Number of shares available for grant (in shares)									13,800,000
Grants in period (in shares)									0
Exercises in period (in shares)									400,000
Weighted average exercise price (in dollars per share) | $ / shares									$ 6.20
Options outstanding (in shares)									1,300,000
Contractual term									1 year 6 months
Options outstanding, intrinsic value | $									$ 28,600
Monetary cap | $			$ 25,000	$ 25,000
Share cap (in shares)			1,000
Offering period duration (in months)			12 months
Number of six-month purchase periods | PurchasePeriod			2	2
Proceeds from stock plans | $									22,896	$ 32,053
Compensation not yet recognized | $									$ 653,600
Period for recognition (in years)									2 years 9 months 18 days
Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average exercise price (in dollars per share) | $ / shares									$ 7.24
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									15,804,000
Granted (in dollars per share) | $ / shares									$ 18.43
Common Class A [Member] | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)			13,800,000	13,800,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)									13,800,000
Percent of eligible compensation (up to)			15%	15%
Purchase price of common stock, percent				85%
ESPP stock issued during period (in shares)									1,000,000
2016 Plan | Common Class A [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)								22,400,000
Annual increase (in shares)								18,000,000
Annual increase, percent of outstanding shares								5%
Number of additional shares authorized	11,300,000	10,700,000
2016 Plan | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from stock plans | $									$ 18,900
Market Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments outstanding (in shares)									2,100,000
Market Stock Units | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)					1,300,000	400,000	700,000
Granted (in dollars per share) | $ / shares					$ 27.89	$ 46.20	$ 35.69
Vesting percentage						200%	133%
Award vesting period					2 years 10 months 24 days	2 years 9 months 18 days	4 years

Equity Incentive Plans - RSU (D

Equity Incentive Plans - RSU (Details) - RSUs	6 Months Ended
	Jan. 31, 2023 $ / shares shares
Number of Shares
Outstanding, beginning balance (in shares) | shares	22,136,000
Granted (in shares) | shares	15,804,000
Released (in shares) | shares	(5,287,000)
Forfeited (in shares) | shares	(3,134,000)
Outstanding, ending balance (in shares) | shares	29,519,000
Grant Date Fair Value per Share
Beginning Outstanding (in dollars per share) | $ / shares	$ 29.81
Granted (in dollars per share) | $ / shares	18.43
Released (in dollars per share) | $ / shares	29.63
Forfeited (in dollars per share) | $ / shares	27.70
Ending Outstanding (in dollars per share) | $ / shares	$ 23.98

Equity Incentive Plans - ESPP (

Equity Incentive Plans - ESPP (Details) - Employee Stock Purchase Plan	6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	10 months 9 days	9 months 7 days
Risk-free interest rate	4%	0.10%
Volatility	64.30%	53.30%
Dividend yield	0%	0%

Equity Incentive Plans - Stock

Equity Incentive Plans - Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 85,290	$ 88,045	$ 166,245	$ 178,592
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	23,570	26,380	44,042	55,512
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	36,491	35,763	75,113	74,242
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	14,944	16,148	29,300	28,882
Product | Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	2,113	1,948	4,272	3,699
Support, entitlements and other services | Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 8,172	$ 7,806	$ 13,518	$ 16,257

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 4,170	$ 5,309	$ 9,613	$ 9,356

Restructuring Charges (Addition

Restructuring Charges (Additional Information) (Details) $ in Millions	1 Months Ended	6 Months Ended	9 Months Ended
	Aug. 31, 2022 Employee	Jan. 31, 2023 USD ($)	Jan. 31, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring description	In August 2022, we announced a plan to reduce our global headcount by approximately 270 employees, which represents approximately 4% of our total employees
Cash payments		$ 4.4
Restructuring Charges			$ 16.5
Accrued compensation and benefits		$ 0.6	0.6
Sales and marketing expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			13.6
Research And Development Expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			2.3
Support entitlements and other services cost of revenue [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			0.4
General and administrative expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			0.2
Employee [Member]
Restructuring Cost and Reserve [Line Items]
Number of employees reduced our global headcount | Employee	270
Number of employees reduced our global headcount, Percent	4%
One-time severance [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges			$ 16.5

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended				6 Months Ended
		Jan. 31, 2023	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2023	Jan. 31, 2022
Earnings Per Share [Abstract]
Net loss		$ (70,790)	$ (99,514)	$ (115,416)	$ (420,206)	$ (170,304)	$ (535,622)
Weighted average shares-basic	[1]	231,924		218,808		230,229	217,153
Weighted average shares-diluted	[1]	231,924		218,808		230,229	217,153
Net loss per share attributable to common stockholders-basic	[1]	$ (0.31)		$ (0.53)		$ (0.74)	$ (2.47)
Net loss per share attributable to common stockholders-diluted	[1]	$ (0.31)		$ (0.53)		$ (0.74)	$ (2.47)
[1] Effective January 3, 2022, all of the then outstanding shares of Nutanix, Inc. Class B common stock were automatically converted into the same number of shares of Nutanix, Inc. Class A common stock. See Note 9 for further details.

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities (Details) - shares shares in Thousands	6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	70,760	69,072
Outstanding stock options and RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	30,841	27,421
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,933	1,683
Common stock issuable upon the conversion of the Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	36,986	39,968

Net Loss Per Share - Additional

Net Loss Per Share - Additional Information (Details) - $ / shares	Jan. 31, 2023	Jul. 31, 2022	Jan. 03, 2022
Common Class A [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.000025	$ 0.000025	$ 0.000025
Common Class B [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock, Par or Stated Value Per Share	$ 0.000025	$ 0.000025	$ 0.000025

Segment Information - Additiona

Segment Information - Additional information (Details)	6 Months Ended
	Jan. 31, 2023 Segment
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of reportable segments	1

Segment Information - Schedule

Segment Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2023	Jan. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 486,495	$ 413,081	$ 920,104	$ 791,598
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	275,407	226,437	531,137	443,587
Europe, the Middle East and Africa
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	121,564	97,584	221,817	181,579
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	79,202	74,844	148,305	140,527
Other Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenue	$ 10,322	$ 14,216	$ 18,845	$ 25,905

Segment Information - Schedul_2

Segment Information - Schedule of Sets Forth Long-Lived Assets Include Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2023	Jul. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 112,584	$ 113,440
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	76,350	74,472
Non-US [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 36,234	$ 38,968